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Abstract 
While psychotherapy treatment manuals define the broad structure and targets of a therapy, therapists 
must decide how to implement treatments with a specific patient. Yet, patients are heterogeneous even 
within a disorder class, and there is little systematic research to guide a therapist to make principled 
adaptations. We examined the question of whether individual differences moderate the treatment effects 
of therapist interventions and both in-session and between-session processes of change, using data from 
a randomized controlled trial for panic disorder comparing panic-focused psychodynamic psychotherapy 
(PFPP) to cognitive-behavioral therapy. In Chapter 1, adherence to PFPP (n = 65) was observer rated in 
Sessions 2 and 10 to predict panic change after the rated session. Panic-specific interpretations 
predicted improvements, while non-panic-focused interventions did not. Concordant with dynamic theory, 
patients with more interpersonal problems benefitted especially from heightened focus on the interplay 
between interpersonal-emotional conflict and panic. In Chapter 2, we examined whether higher levels of 
observer-rated emotional expression—a marker of therapeutic engagement—across early PFPP sessions 
predicted subsequent panic improvements. We hypothesized that this relationship would be moderated 
by certain personality disorder traits related to emotionality: (1) borderline traits, which denote 
heightened, labile, dysregulated emotionality; and (2) obsessive-compulsive traits, related to muted, 
constrained emotionality. As predicted, borderline traits attenuated the otherwise positive relationship 
between emotional expression and symptom improvement, but obsessive-compulsive traits had 
inconsistent relationships between trial sites. Finally, in Chapter 3, we built on mediational analyses for 
both CBT and PFPP (n = 138), examining whether the presence of different psychological vulnerabilities 
moderated the symptomatic impact of improvement in two mediators of panic change: catastrophic, 
body-focused interpretation style, and panic-specific reflective functioning (PSRF). Patients beginning 
treatment with a more catastrophic style benefitted more from improvements in either mediator. 
Personality disorder traits blunted the impact of improvements in PSRF, but patients with no personality 
disorder evidenced high benefit from PSRF improvements. This set of findings suggests that 
personalization of psychotherapy can be empirically grounded. Clinical characteristics may inform how a 
therapist chooses to intervene, what in-session processes they focus on, and what types of psychological 
changes they aim to encourage. 
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 ABSTRACT 
 
WHAT PROCESS WORKS FOR WHOM: INDIVIDUAL DIFFERENCES AND THE 
IMPACT OF THERAPY TECHNIQUES AND TREATMENT MECHANISMS 
John Raymond Keefe 
Robert J. DeRubeis 
While psychotherapy treatment manuals define the broad structure and targets of a 
therapy, therapists must decide how to implement treatments with a specific patient. Yet, 
patients are heterogeneous even within a disorder class, and there is little systematic 
research to guide a therapist to make principled adaptations. We examined the question of 
whether individual differences moderate the treatment effects of therapist interventions 
and both in-session and between-session processes of change, using data from a 
randomized controlled trial for panic disorder comparing panic-focused psychodynamic 
psychotherapy (PFPP) to cognitive-behavioral therapy. In Chapter 1, adherence to PFPP 
(n = 65) was observer rated in Sessions 2 and 10 to predict panic change after the rated 
session. Panic-specific interpretations predicted improvements, while non-panic-focused 
interventions did not. Concordant with dynamic theory, patients with more interpersonal 
problems benefitted especially from heightened focus on the interplay between 
interpersonal-emotional conflict and panic. In Chapter 2, we examined whether higher 
levels of observer-rated emotional expression—a marker of therapeutic engagement—
across early PFPP sessions predicted subsequent panic improvements. We hypothesized 
that this relationship would be moderated by certain personality disorder traits related to 
emotionality: (1) borderline traits, which denote heightened, labile, dysregulated 
emotionality; and (2) obsessive-compulsive traits, related to muted, constrained 
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emotionality. As predicted, borderline traits attenuated the otherwise positive relationship 
between emotional expression and symptom improvement, but obsessive-compulsive 
traits had inconsistent relationships between trial sites. Finally, in Chapter 3, we built on 
mediational analyses for both CBT and PFPP (n = 138), examining whether the presence 
of different psychological vulnerabilities moderated the symptomatic impact of 
improvement in two mediators of panic change: catastrophic, body-focused interpretation 
style, and panic-specific reflective functioning (PSRF). Patients beginning treatment with 
a more catastrophic style benefitted more from improvements in either mediator. 
Personality disorder traits blunted the impact of improvements in PSRF, but patients with 
no personality disorder evidenced high benefit from PSRF improvements. This set of 
findings suggests that personalization of psychotherapy can be empirically grounded. 
Clinical characteristics may inform how a therapist chooses to intervene, what in-session 
processes they focus on, and what types of psychological changes they aim to encourage. 
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Specific Psychodynamic Techniques in Panic Treatment 
 
Panic-focused psychodynamic psychotherapy (PFPP; Busch, Milrod, Singer, & 
Aronson, 2012) is a 24-session, twice weekly brief psychodynamic psychotherapy (PDT) 
formulated for the treatment of panic disorder (PD) with and without agoraphobia. In 
several randomized controlled trials (RCTs), PFPP has been shown to be equivalent in 
efficacy to various forms of cognitive-behavioral psychotherapy (CBT; Beutel et al., 
2013; Keefe, McCarthy, Dinger, Zilcha-Mano, & Barber, 2014; Milrod et al., 2016; 
Milrod et al., 2007). The exception comes from one site of a two-site study at which 
PFPP was inferior to CBT (Milrod et al., 2016). Further trials are underway (Sandell et 
al., 2015). 
The PFPP treatment model is based on the assumption that the acute emergence 
of panic and the developmental vulnerability toward PD has underlying psychological 
meanings related to emotional-interpersonal conflicts and attachment dysregulation 
(Busch, Milrod, & Singer, 1999; Busch et al., 2012). For example, a patient who 
experiences ambivalence regarding a life-long romantic commitment to his partner may 
develop a PD shortly after announcing their engagement. The patient’s panic attacks may 
be triggered by anxious moments of unacknowledged intolerable ambivalence toward his 
partner. He may either be unaware of or perhaps frightened to recognize this ambivalence 
and its potentially frightening consequences, such as breaking up with or losing the 
support of his partner, which could result in a vicious cycle of unrecognized conflicted 
feelings and anxious arousal leading to panic. Consistent with PFPP’s etiological 
hypothesis, patients with PD report higher rates of alexithymia (i.e., difficulty verbalizing 
one’s emotions and motives), experiential avoidance, and lack of emotional acceptance, 
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compared to psychiatrically healthy controls and persons with simple phobias (Galderisi 
et al., 2008; Izci et al., 2014; Parker, Taylor, Bagby, & Acklin, 1993; Tull & Roemer, 
2007).  
One important intervention in PFPP, clarification, is the attempt by the therapist 
to help the patient become aware of the avoided and unconscious intrapsychic conflicts 
that give rise to panic (Busch et al., 2012). This process entails gathering information 
concerning the potential meanings of symptoms and actively helping the patient 
recognize, verbalize, and reflect on those meanings; the context of symptoms also helps 
to identify meanings. Successful clarifications along these lines lay the groundwork for 
accurate interpretations of conflicts. For example, clarification could help the 
aforementioned patient become aware that he habitually assigns frightful somatic sources 
(e.g., heart disease) to anxiety that emerges when he became engaged and works on 
wedding details, triggering intensely mixed feelings about his fiancée. This would enable 
the therapist to help the patient focus on specific causes for these feelings. 
Another important PFPP intervention is interpretation—attempts to help the 
patient identify the specific dynamics and conflicts that underlie PD (Busch et al., 2012; 
Summers & Barber, 2010). Types of interpretations include: (a) defense (i.e., of a 
particular manner in which the patient avoids experiencing a particular distressing feeling 
or issue); (b) dynamic/conflict (i.e., of how a patient’s experiences are the result of a 
conflict between unacceptable wishes and the defenses against these wishes); (c) genetic 
(i.e., of how early, formative attachment relationships may have made the patient’s 
approach to interpersonal situations fraught with specific, identifiable vulnerabilities); 
and (d) transference (i.e., how the patient’s recurring underlying formative attachment 
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patterns and conflicts emerge in the relationship with the therapist) (Busch et al., 2012). 
PFPP therapists should attempt to link, whenever possible, the specifics of the patient’s 
panic symptoms to his/her specific underlying dynamics (Busch et al., 1999; Busch et al., 
2012). A PFPP therapist who treats the engaged PD patient described above might 
interpret that he appears to be afraid of experiencing and expressing his anger with his 
partner. The therapist might cite the observation that the patient frequently talks about 
how much he loves his partner immediately after expressing his frustrations, thereby 
magically “undoing” his anger. The therapist could also point out that the unresolved and 
frightening feelings of anger and frustration seem to emerge as sensations of physical 
discomfort that trigger panic. By doing so, the therapist attempts to help the patient own 
and work through these conflicts, diminishing their power as panic triggers and helping 
the patient attribute any lingering anxiety to personal psychological meanings rather than, 
for example, somatic problems. 
Techniques Contributing to Efficacy in PDT for Anxiety  
Previous studies have demonstrated that use of specific psychodynamic 
techniques is predictive of outcomes in depression and personality disorder treatment 
(Barber, Crits-Christoph, & Luborsky, 1996; Barber, Muran, McCarthy, & Keefe, 2013; 
Hoglend, Dahl, Hersoug, Lorentzen, & Perry, 2011; Levy et al., 2006; McCarthy, Keefe, 
& Barber, 2016). However, there is a lack of empirical evidence supporting the efficacy 
of specific psychodynamic therapy (PDT) techniques for anxiety disorders, with only one 
small sampled study (n = 20) showing that patients whose therapists employed more 
interpretations across two sessions (3 and 9 out of an average of 20 sessions) of short-
term PDT tended to have superior symptomatic outcomes at termination (Pitman, Slavin-
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Mulford, & Hilsenroth, 2014). However, because the authors were unable to establish 
temporal precedence (i.e., that technique use preceded symptom change), a plausible 
account of the finding is that, for instance, patients with better prognoses pulled for more 
interpretations from their therapists in this setting. Moreover, disorders were not 
diagnosed with a reliable measure. Further research is clearly required to investigate the 
efficacy of specific PDT techniques for anxiety. 
When considering the active ingredients that characterize effective PFPP, it 
should be noted PFPP is distinguished from generic short-term PDT through its explicit 
emphasis on panic and its associated dynamics (Busch et al., 2012). Clinical trials in 
which PDTs have been operationalized without a specific focus on the primary 
symptoms, or in which such a focus was proscribed or discouraged, have generated some 
of the most disappointing findings regarding the efficacy of PDTs (Durham et al., 1994; 
Garner et al., 1993; Gilboa-Schechtman et al., 2010; Poulsen et al., 2014). The rationale 
behind PFPP is that by focusing on experiences proximal to panic and by linking 
interpretations coherently to panic vulnerability, patients gain insight as to the specific 
underpinnings of their panic attacks (Rudden, Milrod, Target, Ackerman, & Graf, 2006). 
In PDT and other therapies, gains in insight have been found in different investigations to 
both predict further functional improvements post-treatment as well as protection against 
relapse across follow-up (Barber et al., 2013; Gibbons et al., 2009; Johansson et al., 2010; 
Kallestad et al., 2010). However, the specific hypothesis that psychodynamic focus on 
symptoms promotes greater symptom relief (Summers & Barber, 2010) has never been 
addressed directly in empirical investigations. 
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In the context of a randomized controlled trial of PD with and without 
agoraphobia evaluating manualized PFPP (Milrod et al., 2016), we measured the use of 
psychodynamic psychotherapy interventions in two sessions of psychotherapy taken from 
the early and middle phases of a 24-session treatment protocol (Sessions 2 and 10). Based 
on PFPP’s conceptual model (Busch et al., 2012), we hypothesized that therapists’ more 
frequent use of psychodynamic interpretations made with connections to symptoms of 
and/or vulnerabilities to panic, agoraphobia, or anxiety would predict greater subsequent 
symptom improvement in PFPP. In the PFPP manualization, therapists are expected to, 
on average, focus on clarification of panic meanings in the beginning of treatment, but to 
become progressively more interpretive as these meanings become clearer and the patient 
becomes socialized to psychodynamic treatment (Busch et al., 2012). We hypothesized 
that interpretations in the session taken from the middle phase of treatment (Session 10) 
would be more predictive of improvement than interpretations in the earlier session 
(Session 2), as by the middle phase of treatment the therapist has sufficient information 
about the patient to make meaningful and accurate interpretations (Andrusyna, Luborsky, 
Pham, & Tang, 2006; Crits-Christoph, Cooper, & Luborsky, 1988). We anticipated that 
interpretations made without reference to panic would not predict subsequent symptom 
improvement, when accounting for panic-focused interpretations.  
In addition, we hypothesized that panic-focused clarifications made early on in 
therapy (Session 2) would contribute to prediction of psychotherapy outcomes, as 
clarification in this phase can help the therapist gather information and can encourage 
initial exploration of dynamics underlying the patient’s panic symptoms.  
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Moderators of technique-outcome relationships. Like many manualized 
psychotherapies, PFPP allows for therapist flexibility in focus and application of 
therapeutic techniques (Busch et al., 2012), but relatively little empirical data exist to 
help guide moment-to-moment judgments of how to respond to an individual patient. As 
specific therapeutic techniques can be more or less conducive of change among particular 
patients (Keefe, Webb, & DeRubeis, 2016; Sasso, Strunk, Braun, DeRubeis, & Brotman, 
2015), we furthermore hypothesized that specific patients would be likely to evince 
apparent benefit from particular psychodynamic interventions.  
Specifically, we hypothesized that panic-focused interpretations would be more 
important to outcomes when patients entered the trial with more interpersonal problems 
as measured by the Inventory of Interpersonal Problems (IIP; Horowitz, Alden, Wiggins, 
& Pincus, 2000). Interpersonal conflicts and transitions are frequently stressors 
surrounding the onset of PD (Klass et al., 2009; Scocco, Barbieri, & Frank, 2007), and 
couples in which one patient has PD often exhibit relational distress and avoidant 
conversational and cognitive styles (Chambless, 2010). As unresolved and/or 
unconscious interpersonal conflicts such as intolerable dependency and anger can be 
viewed as a trigger for panic in PFPP, we hypothesized that individuals with more 
interpersonal problems might be more likely to have such conflicts or to have relatively 
more pervasive conflicts, and thus would benefit relatively more from panic-focused 
interpretations addressing those conflicts. In addition, the dynamics associated with 
panic, including difficulties with separation, dependency and anger could contribute to 
both panic and interpersonal problems.  In other words, our hypothesis was based on the 
notion that patients with more interpersonal problems may be more likely to have the 
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dynamic-interpersonal contributions to panic that panic-focused interpretations may 
specifically help reveal and resolve. 
Method 
Participants  
Patients. The present study is a secondary analysis of patients randomized to the 
PFPP condition (N = 80) of a two-site randomized controlled trial comparing PFPP, 
CBT, and applied relaxation training among patients with primary DSM-IV panic 
disorder with or without agoraphobia. Treatment took place twice a week for 12 weeks. 
Patients were recruited at New York Presbyterian/Weill-Cornell (hereafter, “Site A”) and 
the University of Pennsylvania (hereafter, “Site B”). Participants received study treatment 
gratis. Participants gave informed written consent. Both sites’ institutional review boards 
approved the protocol, and the study is registered with ClinicalTrials.gov (identifier: 
NCT00353470).  
Patients were included in the trial if they had the spontaneous occurrence of one 
or more panic attacks for the month before trial entry, and qualified for DSM-IV panic 
disorder diagnosis determined as per the ADIS-IV (DiNardo, Brown, & Barlow, 1995). 
Cross-site agreement on ADIS ratings for panic severity (with a “4” indicating the 
diagnostic threshold) was excellent (ICC = 1.00). See Milrod et al., 2016 for further 
details. 
Non-study psychotherapy was prohibited. Medications were permitted if stable 
for at least two months at presentation, and were recorded, held constant, and monitored 
during the trial. Exclusion criteria were active substance dependence (less than 6 months’ 
remission), a history of psychosis or bipolar disorder, acute suicidality, and organic 
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mental syndrome. Additional details on trial design, independent evaluator training, and 
therapy adherence can be consulted in the primary outcome paper (Milrod et al., 2016). 
Of the 80 randomized patients, 65 (n = 30 Site A, n = 35 Site B) provided the 
necessary data to be included in the present study (see section on missing data). 
Descriptive data on patients’ demographics may be found in Table 1.  
 Therapists. Sixteen doctoral-level therapists (11 M.D., 5 Ph.D.) administered 
PFPP across the two sites. Therapists had an average of 15 years of post-graduate 
experience (SD = 8.2), and an average of 5 years’ experience in some form of time-
limited psychodynamic therapy (SD = 6.3). The average total caseload was four (median 
= 3.5, range = 1 to 11) for therapists whose patients were included in the present 
analyses. All therapists were experienced therapists who were specifically trained in 
PFPP over the span of a 2-day, 10-hour course. Therapists participated in monthly group 
supervision and received regular individual supervision from senior clinicians. For the 
primary outcome paper, basic adherence to PFPP was established (Milrod et al., 2016). 
Outcome Index 
Panic Disorder Severity Scale (PDSS; Shear et al., 1997). The PDSS is a 
widely used diagnosis-based, composite, global rating of panic disorder severity, with 
acceptable psychometric properties. The PDSS was administered by trained, master’s-
level independent evaluators who were uninformed as to treatment condition. Interrater 
reliability on the PDSS was excellent (ICC[2,1] = 0.95). The PDSS was administered five 
times during treatment: at baseline (Week 0), Week 1, Week 5, Week 9, and termination 
(Week 12).  
Moderator Measures 
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Inventory of Interpersonal Problems—Circumplex (IIP; Horowitz et al., 
2000)). The IIP-Circumplex is a 64-item self-report measure of maladaptive interpersonal 
problems that is a shorter version of the full 127-item IIP. The sum score of the IIP 
reflects an individual’s degree of interpersonal distress. The IIP exhibits adequate internal 
reliability and 10-week test-retest reliability (Alden, Wiggins, & Pincus, 1990), and 
exhibited excellent internal reliability in this sample (alpha = 0.95). 
Process Measure 
Panic-Focused Psychodynamic Psychotherapy Rating Scale (PFPP-RS; 
Keefe, Phillips, Busch, & Milrod, 2016). The PFPP-RS is an observer-rated scale 
developed to assess the degree to which therapists used general psychodynamic 
interpretive techniques, as well as more specific panic-focused psychodynamic 
techniques. It was developed by the author JRK in conjunction with PFPP developers 
Fred Busch and Barbara Milrod. The use of each technique was rated on a 5-point Likert 
scale ranging from 0 (technique not present in section) to 2 (at least one clear example of 
the technique in section) to 4 (technique applied fully and comprehensively in section). 
Scores reflected the degree to which a technique was prototypic to the rated segment (i.e., 
adherence), not whether the raters believed the therapist applied the technique in a 
particularly apt way (i.e., competence). For items measuring the use of interpretation, a 
score of 2 would indicate that the therapist made at least one clear, identifiable 
interpretation. A score of 4 could represent either multiple individual interpretations 
made within a rating segment, or a single, continually developed interpretation over an 
extended period of time. Sessions were divided into 15-min segments, with each segment 
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rated for each technique. A single rating per session was calculated by averaging ratings 
made across the three 15-min segments.  
Scores of the PFPP-RS items were summed to produce the following subscales: 
(a) Psychodynamic Interpretations – the degree to which the therapist used any of the 
four types of interpretations (defense, genetic, dynamic, and transference); and (b) Panic-
Focus: the degree to which the therapist focused on panic, agoraphobia, and anxiety 
symptoms and made connections between these symptoms and panic dynamics, including 
underlying conflicts. For Panic-Focus items, to score a 2 or higher on any given item, a 
therapist had to make a clear, unambiguous reference to panic, agoraphobia, or anxiety in 
relation to the intervention. This subscale includes two items assessing use of 
clarification with regard to panic symptoms and their personal meaning (PF-
Clarification), and three items assessing interpretations that address the emergence of and 
vulnerability to experiences of panic, agoraphobia, and anxiety (PF-Interpretation). 
Examples of therapist interventions qualifying as clarifications and interpretations can be 
found in Supplemental Table 1. To separate panic-focused interpretations from non-
panic-focused interpretations, the PF-Interpretation subscore was subtracted from the 
total Psychodynamic Interpretations score, as PF-Interpretations reflect a subset of 
Psychodynamic Interpretations. This score will be referred to as Non-Panic-Focused 
Interpretations.  
Video-recorded sessions were rated using the PFPP-RS by six advanced 
undergraduate psychology majors at the University of Pennsylvania who each received 
approximately 20 hours of training by the developers of the scale. Two authors who were 
PFPP developers (FB & BR), and a graduate student author familiar with the model (NS) 
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provided additional consultation as to the validity and reliability of ratings during 
training. Training included a review of the rater manual, the PFPP therapy manual (Busch 
et al., 2012), and rating of several training tapes of PFPP. Training was continued until 
raters consistently rated single items within a point (+/-) of their graduate student trainer. 
Additionally, raters met approximately every other week with the study leader JRK to 
rate a tape collectively and discuss rating challenges and questions.  
All available Sessions 2 and 10 were rated for each PFPP patient. Sessions 3 and 
9 were rated in cases wherein Session 2 or 10 (respectively) was not available. Sessions 
were randomly assigned to raters, who were uninformed of the outcome data.  Two raters 
rated each tape, and ratings were averaged across raters. 
Random effects ICCs were calculated using variance estimates from an REML 
mixed model in the R package “lme4” (Bates et al., 2016; Shrout & Fleiss, 1979). 
Interrater reliability per 15-minute segment was good for all Psychodynamic 
Interpretations (ICC[2,2] = 0.80) and adequate for Panic-Focused Clarification (ICC[2,2] 
= 0.71), Panic-Focused Interpretations (ICC[2,2] = 0.70), and the difference score 
reflecting Non-Panic-Focused Interpretations (ICC[2,2] = 0.68).   
Statistical Analyses 
All analyses were conducted using the R statistical programming language (R 
Core Team, 2017) and run using robust regressions as implemented in the R package 
“Robustbase” (Maechler et al., 2016). Given the effective sample size (n = 65), robust 
regression was selected over standard regression for its superior properties of robustness 
against multivariate outliers and deviation from homoscedasticity (Huber & Ronchetti, 
2009). A robust regression (a) retains full information on all observations in an initial 
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estimate of parameters; (b) iteratively determines weights for each observation based on a 
particular estimator function from this initial estimate, such that points much farther from 
model predictions in the previous iteration are given lower weight; and (c) recalculates 
final parameter estimates based on the final weighting when the values of the coefficients 
converge within a specified tolerance (Koller & Stahel, 2011). Semi-partial correlation 
effect sizes (sr) were estimated for parameters of interest from linear regressions.  
Missing data. In the primary trial, a not missing at random (NMAR) pattern of 
treatment dropout was detected, such that patients with worse PDSS symptom trajectories 
were more likely to terminate from treatment prematurely (Milrod et al., 2016). When 
outcomes for treatment noncompleters are imputed in the NMAR context, imputation and 
other missing data methods can lead to biased estimates and confidence intervals 
(Graham, 2009). As such, only individuals who provided data up to the Week 9 
assessment point were included in our analyses (n = 65; 81.3% of the intention-to-treat 
sample). 
Several trial completers were missing videotapes of one of the two sessions due to 
technical issues or therapist/research assistant error (n = 27), but not treatment dropout. 
Process ratings for completers missing a video-recording of a session can be presumed to 
be missing at random in relation to panic symptom outcomes (Rubin & Little, 2002). This 
degree of missingness is not considered prohibitive in the missing data literature (White, 
Royston, & Wood, 2011), and process ratings have been successfully imputed in the past 
(e.g., Forand et al., 2018; Lorenzo-Luaces et al., 2017). Accordingly, random forest 
imputation (Stekhoven & Bühlmann, 2011) was used to impute missing data for 
completers, using all baseline data, in addition to all PDSS scores and termination and 
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pre-to-post treatment change scores on the Sheehan Disability Scale, Inventory of 
Interpersonal Problems, and Hamilton Rating Scale for Depression. Furthermore, all 
rated technique process ratings from observed sessions (the non-missing session and 
Session 5, which was rated but not used in this manuscript) were included in the 
imputation model, such that all patients had observed session process during their therapy 
contributing to the imputation of their missing session ratings. For this data set, a 
normalized root mean square error of prediction was estimated at 0.28, indicating that 
imputation accuracy was adequate (Stekhoven & Bühlmann, 2011). Analyses for patients 
with complete data for a given session were also run and compared to imputed data. No 
changes in patterns of statistical significance were detected. 
Analytic strategy. Two sets of analyses were performed. Within a robust linear 
regression framework (Koller & Stahel, 2016), technique use at Session 2 (end of Week 
1) was used to predict PDSS symptom change between Weeks 1 and 5 of treatment, 
while technique use at Session 10 (end of Week 5) was used to predict symptom change 
between Weeks 5 and 9 of treatment. For two reasons, we examined change in the 
symptom measurement interval following the sampled session rather than the entire 
remainder of the therapy: (a) This permitted establishment of closer temporal precedence 
between techniques and outcomes than is often performed in “long reach” studies that 
sample from an early session to predict change throughout the entire treatment (e.g., 
Keefe et al., 2016) ; and (b) as improvement in the trial was linear and technique use 
following the sampled session may also influence symptom change, using too large a 
prediction interval may obfuscate the signal of how technique use occurring in the 
sampled session per se relates to subsequent symptom change.  
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Three process terms were included in each regression unless otherwise specified: 
PF-Interpretation, PF-Clarification, and Non-PF-Interpretation. In each analysis, baseline 
PDSS symptom score and PDSS change prior to the measured session were included as 
covariates. Prior panic symptom levels were included as a covariate to allay the 
possibility that patients who were low severity or getting better could have “pulled” for 
more or fewer techniques, generating an epiphenomenal relationship. Due to a site by 
treatment interaction reported in the primary outcome paper across the three tested 
treatments (Milrod et al., 2016), we also examined whether any process measures 
interacted with site to predict outcomes, and we planned to report any such interactions if 
they were found at least at trend level (p <.10). However, no such interactions with site 
were detected, suggesting that process relationships were not detectably different across 
sites. 
Furthermore, IIP scores were examined as a moderator of the relationship of 
Session 10 panic-focused interpretations to subsequent change, tested by specifying an 
interaction between the two variables. The Johnson-Neyman technique was applied to 
probe the regions of significance of the interaction (Johnson & Fay, 1950). 
 Given that we conducted seven statistical tests, we adjusted p-values using the 
Benjamini-Hochberg correction to control for the false discovery rate at an alpha of 0.05 
(Benjamini & Hochberg, 1995), employing the core R function “p.adjust.” These are 
reported as adjusted p-values.  
In addition, we conducted two secondary, post-hoc statistical checks on the 
robustness of our obtained findings. In the first, we employed a mixed model to estimate 
therapist-level variance simultaneously with our model estimates, which did not result in 
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substantively different conclusions. In the second, we analyzed whether the technique 
variables related to pre-to-post treatment functional and interpersonal outcomes. Both 
analyses are reported in Appendix B. 
Results 
Descriptive Statistics 
The average patient in this study had a baseline PDSS score of 13.9 (range 7 to 
20), considered to be in the moderately-ill severity range for patients with comorbid 
agoraphobia (Furukawa et al., 2009). More than three-quarters of patients (n = 53; 
81.5%) qualified for a co-morbid DSM-IV diagnosis of agoraphobia. The average patient 
reported interpersonal problems in the high-normal range of severity (approximately 
+0.64 SD over the normative mean). Other baseline demographic and clinical 
information can be found in Table 1. 
Technique scores at Sessions 2 and 10, as well as indices of their consistency over 
time, are presented in Table 2. Reliable within-patient stability between sessions was 
observed only for panic-focused interpretations. Within a given case, mean levels of 
panic-focused and non-panic focused interpretations increased from Session 2 to Session 
10.  
Prior to data analysis, the correlations between every process measurement and 
baseline PDSS severity and our proposed moderator variable (IIP scores) were examined. 
As displayed in Table 3, there were no significant correlations between baseline panic 
and interpersonal problem severity and any of the technique variables at either time point.  
Early Panic Symptom Change (Weeks 1 to 5) 
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 There was no significant relationship between panic-focused clarifications at 
Session 2 (end of Week 1) and symptom change between Weeks 1 to 5 (B = 1.16 [95% 
CI: -0.20, 2.52], SE = 0.68, t[59] = 1.71, p = 0.092, adjusted p = 0.184, sr = 0.21). 
Neither panic-focused interpretations (B = -1.34 [95% CI: -3.32, 0.64], SE = 0.99, t[59] = 
-1.35, p = 0.181, adjusted p = 0.290, sr = -0.15) nor non-panic focused interpretations (B 
= -0.60 [95% CI: -2.88, 1.68], SE = 1.14, t = -0.53, p = 0.599, adjusted p = 0.599, sr = -
0.09) yielded significant predictions of symptom change in the subsequent measurement 
interval.  
Later Panic Symptom Change (Weeks 5 to 9) 
 Higher levels of panic-focused interpretations at mid-treatment (Session 10, end 
of Week 5) predicted greater panic symptom improvement between Weeks 5 and 9 (B = 
1.79 [95% CI: 0.61, 2.97], SE = 0.59, t = 3.04, p = 0.004, adjusted p = 0.016, sr = 0.37), 
subsequent to the measured session. By contrast, non-panic focused interpretations were 
unrelated to subsequent outcomes (B = -0.47 [95 CI: -1.54, 0.60], SE = 0.54, t[59] = -
0.88, p = 0.382, adjusted p = 0.437, sr = -0.09). Panic-focused clarification at this session 
was also unrelated to outcomes (B = -0.56 [95% CI: -1.37, 0.25], SE = 0.41, t[59] = -1.38, 
p = 0.175, adjusted p = 0.351, sr = -0.20). Figure 1 summarizes all technique-outcome 
relationships for early and later panic symptom change. 
Interpersonal Problems as a Moderator of Technique-Outcome Relationships 
 The higher the score on the IIP at intake, the stronger the relation of panic-
focused interpretations at Session 10 was to subsequent symptom change (B = 3.65 [95% 
CI: 1.24, 6.05], SE = 1.20, t[57] = 3.04, p = 0.004, adjusted p = 0.016, sr = 0.29). The 
Johnson-Neyman technique identified an IIP score of 1.0 as the cutoff for exhibiting a 
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significant, positive relationship between panic-focused interpretations and subsequent 
improvement (n of individuals with IIP > 1.0 = 38, 58.5%; see Figure 2). For patients 
with scores greater than or equal to 1.0, indicating higher levels of interpersonal problems 
at baseline, there was a significant relation between panic-focused interpretations and 
subsequent symptom improvement (sr = 0.41, p = 0.001), whereas for patients with less 
interpersonal distress the association was not significant (sr = 0.11, p = 0.255), in large 
part because patients with lower interpersonal distress did well symptomatically 
regardless of interpretation level (see Figure 2).  
Discussion  
We investigated the relation between use of specific PFPP techniques and 
symptomatic outcomes in the treatment of panic disorder. Our first important finding 
suggests that at mid-therapy (Session 10), panic patients receiving a high level of panic-
focused interpretations exhibited greater subsequent symptom improvement. However, 
non-panic-focused interpretations did not predict subsequent symptom improvement 
during either the earlier or later periods of treatment. Moreover, panic-focused 
interpretations at Session 10 also predicted to pre-to-post improvements in interpersonal 
functioning (see Appendix B). These findings lend support to the importance of taking a 
symptom-focused approach in short-term psychodynamic therapies for anxiety (Busch et 
al., 2012; Tasca, Hilsenroth, & Thompson-Brenner, 2014). Past process findings 
demonstrating a positive relationship between interpretations and symptom change 
(Pitman et al., 2014) could reflect that many interpretations in short-term psychotherapy 
in fact are symptom-focused, even when that is not the specific intent of the study. 
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On the other hand, interpretations in an early session, whether or not they were 
related to panic symptoms, did not predict subsequent panic symptom improvement over 
the following four weeks. Possibly, early interpretations are not as accurate as those made 
after the therapist has learned more about the patient. In previous psychodynamic process 
studies, observer-rated accuracy of interpretations derived from themes coded from early 
session transcripts or pre-treatment history interviews predicted greater symptom change 
and likelihood of having a “sudden gain” (Andrusyna et al., 2006; Crits-Christoph et al., 
1988). Alternatively, interpretation at a very early stage may sometimes be experienced 
by the patient as overwhelming (McCarthy et al., 2016). At an early stage of therapy, it is 
also potentially less likely that patients have been fully socialized to the both the structure 
and tasks and goals of psychodynamic therapy (Luborsky, 1984), which may make it 
harder for them to build on therapists’ interpretations with further personal exploration 
and development of insight.  
Taken together, it is possible that early interpretations are both less accurate to the 
patient’s dynamics, and less likely to be perceived by the patient as well-timed, which 
may be considered matters of intervention competence. Future process studies on 
interpretation accuracy and the role of supportive techniques and alliance in PFPP would 
help distinguish between these and other hypotheses explaining our findings. However, 
our findings do not support the conclusion that the other types of dynamic techniques 
assessed are necessarily without use or are counterproductive, but rather that panic-
focused interpretations are the only statistically reliable signal of positive process for the 
average patient in this sample. It is also plausible that more complex process relationships 
exist (e.g., interactions between early and mid-technique use; levels of clarification and 
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interpretation), but we did not explore these possibilities due to our need to limit the 
number of tests performed in this small sample.  
As we hypothesized, patients with more interpersonal problems at baseline 
exhibited a stronger relationship between mid-therapy panic-focused interpretations and 
subsequent change. This finding is consistent with PFFP’s theoretical model, which 
proposes that unconscious conflict in the context of relationships may contribute to 
experiences of panic, such that patients with more interpersonal distress may need a more 
intense focus on the emotions and conflicts underlying this distress (Busch et al., 2012). 
Panic dynamics are typically interwoven with the interpersonal problems that these 
patients struggle with. For example, many panic patients are prone to being in 
relationships where they struggle to assert their own needs (Zilcha-Mano et al., 2015). 
This linkage may allow for more readily identifiable dynamics and conflicts, and more 
opportunities to identify them in relation to interpersonal difficulties, compared to 
patients with relatively fewer interpersonal problems. Ergo, it may be the case that 
therapists were more accurate in their interpretations for patients with stronger 
interpersonal issues.   
However, patients with lower levels of interpersonal problems had good symptom 
improvement in this interval (i.e., between Weeks 5 to 9) regardless of panic-focused 
interpretations, whereas increasing interpersonal distress was more predictive of poor 
symptom improvement in less panic-focused interpretive therapies (see Figure 2). We 
would argue that this pattern of results is concordant with the perspective that patients 
with more interpersonal problems particularly need a more panic-focused, interpretive 
therapy. Past psychodynamic process-outcome research has rarely sought to identify 
20 
 
 
 
beneficial matches between techniques and patient characteristics, with one exception 
being the body of literature suggesting an important role for transference interpretations 
in treating personality disorder (Hoglend et al., 2011; Keefe & DeRubeis, 2018). Overall, 
our finding is consistent with a perspective wherein patients with more complicated or 
treatment-resistant presentations may require more active or skillful approaches, and may 
reveal more about process-outcome relationships than those DeRubeis and colleagues 
(2014) have called “easier” (or more straightforward) patients (DeRubeis, Gelfand, 
German, Fournier, & Forand, 2014; Keefe et al., 2016).   
Limitations and future directions 
Fifteen cases (18.8%) were unable to be used for the present analyses due to 
dropout, which was nonrandom and related to poorer symptom trajectories in the parent 
trial (Milrod et al., 2016). The remaining patients included in our study represent a 
subsample of individuals who improved relatively more symptomatically. It is possible 
that the observed technique-outcome relationships would not be obtained among the 
dropout patients; alternatively, relatively less efficacious therapy process may have led to 
worse symptom trajectories, promoting dropout. Examining the relationship between 
technique use and treatment dropout would be an interesting way to disambiguate these 
possibilities, although this effort would be poorly powered in our sample due to the low 
base rate of dropout and lack of early therapy tapes due to dropout. In addition, several 
sessions were not available to be rated due to protocol error. However, we employed a 
standard, validated method for imputing the missing ratings (Stekhoven & Bühlmann, 
2011), and results obtained with data only from cases with complete data mirrored those 
obtained when the imputations were included.  
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The patterns obtained using ratings from early and middle sections of therapy 
were observed using only one session from each phase. A better approach would be to 
sample multiple sessions from each phase (Dennhag, Gibbons, Barber, Gallop, & Crits-
Christoph, 2012). Unfortunately, at one of the two treatment sites, only recordings of 
Sessions 2, 5, and 10 were available on a systematic basis. Future studies that include 
ratings of multiple recordings within the same interval would allow for the investigation 
of more complex patterns of the relation between process and symptom change, such as 
variability in technique use across sessions (Owen & Hilsenroth, 2014). In addition, the 
average therapy was not intensely interpretive (e.g., at session 10, less than one panic-
focused interpretation per fifteen minutes), indicating that we could not meaningfully 
examine hypotheses that that intensities of interpretations in between the extremes is 
more effective than very low or very high intensities (see McCarthy et al., 2016).  
 Finally, our findings suggest but cannot confirm the presence of a causal 
relationship between the intensity of panic interpretations and symptom change. A 
stronger test of the causal hypothesis would require experimental manipulation of the 
causal variable, in a manner like Hoglend et al.’s (2008) randomized comparison of 
psychodynamic therapy with versus without transference interpretations.   
Conclusions 
 Psychodynamic therapists implementing PFPP should focus on interpretation of 
the possible conflicts underlying panic as they enter the middle phase of therapy. 
Particularly tying the patient’s dynamics to experiences of panic, anxiety, and 
agoraphobia—rather than making general interpretations concerning relational or 
personal patterns—may be especially important for effective short-term treatment of 
22 
 
 
 
panic. For patients presenting with higher levels of interpersonal distress, an emphasis on 
panic-focused interpretations may be especially important in promoting remission from 
panic disorder.  
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Table 1.1 
Descriptive Data for Baseline Characteristics and for Symptom Change 
Baseline Measure Mean (SD) or # (%) 
Baseline PDSS 13.9 (3.2) 
PDSS Change Week 1 to 5 -1.5 (3.6) 
PDSS Change Week 5 to 9 -1.2 (3.4) 
SDS 16.1 (6.3) 
HAM-D 10.6 (4.8) 
IIP 1.2 (0.5) 
Agoraphobia Diagnosis 53 (81.5%) 
Age 39.5 (14.0) 
Gender (Female) 44 (67.7%) 
Ethnicity (Hispanic) 8 (12.3%) 
Race (Black, Other Non-Caucasian) 11 (16.9%), 4 (6.2%) 
Concurrent Psychopharmacology 16 (24.6%) 
Age of Panic Onset (years) 27.5 (11.4) 
SCID-II PersD Diagnosis 32 (49.2%) 
Cluster A PersD Traits 1.4 (1.9) 
Cluster B PersD Traits 2.7 (3.2) 
Cluster C PersD Traits 4.0 (3.1) 
Total PersD Traits 8.0 (6.3) 
Note. HAM-D = Hamilton Rating Scale for Depression; IIP = Inventory of Interpersonal 
Problems; PDSS = Panic Disorder Severity Scale; SCID-II = Structured Clinical 
Interview for the Diagnosis of Axis-II Disorders; SDS = Sheehan Disability Scale 
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Table 1.2  
Descriptive Statistics for Technique Process Measurements (Average per 15-minute 
Segment) 
Process Measurement Session 2 
M (SD) 
Session 10 
M (SD) 
Stability 
Coefficient 
Change in 
Technique Use 
Panic-Focused 
Interpretation 
   0.9 (0.6) 1.2 (0.7)        r = 
0.50*** 
      d = 0.55*** 
Panic-Focused 
Clarification 
   2.3 (1.0) 2.3 (1.1) r = 0.09 d = 0.11 
Non-Panic-Focused 
Interpretations 
   0.2 (0.4) 0.5 (0.6) r = 0.03    d = 0.53** 
Note. * = p <.05; ** = p <.01; *** = p <.001; Cohen’s d for paired t test calculated using 
formula tc (Dunlap, Cortina, Vaslow, & Burke, 1996) 
 
 
Table 1.3  
Correlations between Technique Process Measurements and Baseline Characteristics 
Baseline 
Characteristic 
Panic Focus—
Interpretation 
(S2/S10) 
Panic Focus—
Clarification 
(S2/S10) 
Non-Panic Focused 
Interpretations 
(S2/S10) 
PDSS r = -0.06 / -0.00 r = -0.13 / 0.08 r = -0.12 / 0.07 
IIP r = 0.19 / 0.06 r = -0.07 / -0.02 r = -0.03 / 0.24 
Note. All ps > .05. IIP = Inventory of Interpersonal Problems, PDSS = Panic Disorder 
Severity Scale 
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Figure 1.1. Estimated effect sizes for the relationship between psychotherapy technique 
use at a given session and subsequent improvement in panic symptoms as measured by 
the PDSS. Positive semipartial correlations indicate that higher levels of the intervention 
are associated with more subsequent symptom improvement. Bars are 95% confidence 
intervals.  
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Figure 1.2. Estimated change in panic symptoms as measured by the PDSS between 
Weeks 5 to 9, as a function of degree of interpersonal problems as measured by the IIP 
and their interaction with use of panic-focused interpretations at session 10. Positive 
values represent predicted symptom worsening, while negative values represent predicted 
symptom improvement. All regression variables not displayed in the figure were set to 
the sample means. 
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Patient Personality and Emotional Process  
 
Panic-focused psychodynamic psychotherapy (PFPP) (Busch, Milrod, Singer, & 
Aronson, 2012) is a 24-session, 12-week evidence-based treatment for panic disorder 
(PD; Beutel et al., 2013; Keefe, McCarthy, Dinger, Zilcha-Mano, & Barber, 2014; Milrod 
et al., 2016; Milrod et al., 2007) that focuses on understanding and working through 
unrealized or disavowed meanings surrounding the onset of acute attacks and associated 
anxiety in patients with panic disorder. One common meaning might be real or imagined 
loss of attachment figures, as suggested by epidemiological data showing high 
comorbidity or past history of separation anxiety among panic patients (Kossowsky et al., 
2013; Milrod et al., 2014), and the fact that emotional stressors, such as relationship 
conflict and interpersonal loss, frequently precede the development of panic disorder 
(Klass et al., 2009; Scocco, Barbieri, & Frank, 2007). Recognizing the sometimes-
conflicted emotions and fantasies connected with experiences of panic and anxiety (such 
as unacknowledged rage at attachment figures) is hypothesized to improve panic-specific 
reflective functioning (PSRF; Rudden, Milrod, Target, Ackerman, & Graf, 2006). PSRF 
is an interview-based measured intended to tap into the degree to which patients can 
identify and discuss potential psychological meanings surrounding and triggers to 
experiences of panic and anxiety (Rudden et al., 2006). Early improvement in PSRF has 
been shown to predict subsequent improvement in panic symptoms in both PFPP and 
cognitive-behavioral therapy (CBT) (Barber et al., under review). 
The theory that informs CBTs for panic disorder focuses on patients’ tendencies 
to catastrophically misinterpret bodily sensations (Clark et al., 1997) and thereby to fear 
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those sensations (Boswell et al., 2013). However, specific problems in emotional 
recognition and acceptance have also been observed in studies of patients with panic 
disorder, suggesting that these factors may also contribute to panic experiences. Patients 
with PD report higher rates of alexithymia, experiential avoidance, and lack of emotional 
acceptance, compared to psychiatrically healthy controls and persons with simple phobias 
(Galderisi et al., 2008; Izci et al., 2014; Parker, Taylor, Bagby, & Acklin, 1993; Tull & 
Roemer, 2007). Relative to non-psychiatric controls, panic patients have also been 
observed to use relatively more emotional avoidance strategies in response to viewing 
negatively or positively-valenced film clips (Tull & Roemer, 2007). Experimentally 
instructing use of such strategies in healthy controls (relative to allowing emotional 
experience) promotes subjective distress, heightened physiological arousal in the 
moment, and also physiological reactivity in a subsequent stressful interpersonal task 
(Tull, Jakupcak, & Roemer, 2010).  
Avoidance of emotions in day-to-day life may promote development of panic 
attacks if emotional contents are not addressed—for example, a person may get strongly 
physiologically aroused due to unacceptable emotions, but be unable to dissipate that 
arousal due to lack of emotional awareness and a consequent inability to acknowledge 
what is upsetting him/her. A patient may also attribute emotional arousal to frightening 
somatic causes that can psychologically stand in for conflicted feelings. In support of this 
conceptualization, a recent process study of CBT for panic disorder found that reductions 
in patient reports of emotional suppression preceded improvements in catastrophic, body-
focused cognitions and panic symptoms (Strauss, Kivity, & Huppert, 2018).  
Emotions and Outcome in Psychodynamic Therapies  
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Psychodynamic frameworks conceptualize attempts to avoid affects and particular 
affectively charged contents as contributing to the emergence of psychiatric symptoms 
and psychosocial dysfunction (Subic-Wrana et al., 2016). Within these frameworks, 
defense mechanisms work to maintain lack of awareness (Perry & Bond, 2012), which 
occurs to protect the person from experiencing psychic danger, yet precludes the 
individual’s ability to process and address the relevant conflicts or wishes. Panic patients 
have been observed to have heightened use of so-called neurotic and immature defenses 
relative to healthy controls (Busch, Shear, Cooper, Shapiro, & Leon, 1995; Calati, Oasi, 
De Ronchi, & Serretti, 2010; Kipper et al., 2004), and to exhibit a unique defensive 
profile compared to depression patients (Busch et al., 1995).  
Therapeutic focus on difficult-to-express or disavowed affect has been commonly 
considered to be a feature distinguishing psychodynamic therapies (PDT) from cognitive-
behavioral approaches (Blagys & Hilsenroth, 2000; McCarthy & Barber, 2009). In PDT, 
such focus can be achieved via supportive interventions encouraging expression of affect, 
clarification/confrontation highlighting important areas of affective exploration, or 
interpretations of affectively-laden meanings. In a meta-analytic examination, 
psychodynamic therapies in which therapists were coded by observers as being especially 
affect-focused were more successful in symptomatic outcomes, with a medium effect size 
(Diener, Hilsenroth, & Weinberger, 2007), although temporal precedence was not 
established in most studies and some studies in fact involved patient expression. In two 
recent studies assessing psychodynamic therapist technique specifically in anxiety 
disorder therapies (Pitman, Slavin-Mulford, & Hilsenroth, 2014) and in a transdiagnostic 
sample examining anxiety symptom improvement (Pitman, Hilsenroth, Weinberger, 
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Conway, & Owen, 2017), higher focus by the therapist on unexpressed/avoided affects 
was related to more pre-to-post treatment symptom improvement. 
 In PDTs, links (often temporally sequenced) have been found between the degree 
to which a patient engages in emotional experiencing or processing and positive 
outcomes (Abbass, Town, Ogrodniczuk, Joffres, & Lilliengren, 2017; Fisher, Atzil-
Slonim, Bar-Kalifa, Rafaeli, & Peri, 2016; Friederich et al., 2017; Johansson, Town, & 
Abbass, 2014; Kramer, Pascual-Leone, Despland, & de Roten, 2015; Town, Abbass, & 
Bernier, 2013; Town, Salvadori, Falkenström, Bradley, & Hardy, 2017), convergent with 
findings in humanistic-experiential therapies (Pascual-Leone & Yeryomenko, 2016). A 
recent meta-analysis suggested that, across psychotherapies and psychiatric disorders, 
increased expression of emotion by the patient although many of the included studies had 
unclear temporal precedence between the affective measurement and outcome (Peluso & 
Freund, 2018). In their transtheoretical conception of the importance of emotional 
expression and experiencing in psychotherapy, Lane, Ryan, Nadel, & Greenburg (2015) 
propose that emotional activation of episodic and semantic memory content facilitates the 
reconsolidation of those memories into new, potentially more adaptive forms. From a 
psychodynamic perspective, heightened affective experiences in therapy may indicate 
that a patient is tolerating more affectively charged material, allowing for working 
through of conflicts and ultimately improvements in reflective functioning. Heightened 
patient emotional experiencing has been examined as a positive predictor of improvement 
in a study of intensive short-term psychodynamic therapy for patients with generalized 
anxiety disorder (Lilliengren, Johansson, Town, Kisely, & Abbass, 2017), but we are not 
aware of any other such study in anxiety. 
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Study Hypotheses: Main Effects and Moderators  
 PFPP’s clinical theory predicts that patient affective engagement is important to 
exploration of meanings and conflicts surrounding panic and anxiety experiences (Busch 
et al., 2012). To examine the relationships between early in-session emotional 
engagement and subsequent changes in symptoms and PSRF, we developed a measure of 
in-session emotional expression. Emotional expression can be thought of as a broad 
process marker of engaged emotions, incorporating basic aspects of both emotional 
experience (i.e., does the patient exhibit non-verbal signs of emotional activation?; 
McCullough et al., 2003) and processing (i.e., does the patient speak in an identifiable 
manner about specific, current emotional experiences; Klein, Mathieu, Gendlin, & 
Kiesler, 1969; Pascual-Leone & Greenburg, 2005)? Levels of emotional expression were 
assessed in early sessions (2, 5, and 10) of a 24-session PFPP protocol from a two-site 
randomized controlled trial comparing PFPP to CBT and applied relaxation training for 
panic (Milrod et al., 2016). We hypothesized that patients with higher levels of emotional 
expression in early PFPP sessions would experience greater symptom and PSRF 
improvement subsequent to the process-measured sessions. Moreover, we examined both 
overall patient emotional expression and expression of specific emotional states, to help 
determine whether patient engagement with particular affects is especially important to 
treatment process (e.g., grief; anger) or potentially deleterious to treatment (e.g., anxiety 
in-session, as might be predicted by psychodynamic conflict models). 
 Moderators. Although many psychotherapy processes are thought of as 
universally positive (e.g., the therapeutic alliance), it may be that some processes are 
more important in some psychotherapies, relative to others. Also, the same process, 
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depending on traits that can capture an aspect of specific functioning relating to affect, 
may yield strong positive effects in some patients, little effect in others, and negative 
effects in still others (cf. Lorenzo-Luaces et al., 2017). We hypothesized that patient 
personality disorder traits related to constrained (obsessive-compulsive personality 
disorder; OCPD) versus heightened (borderline personality disorder; BPD) affect would 
moderate the relationship between emotional expression and symptom improvement.  
 A psychodynamic conception of OCPD might focus on OCPD patients’ tendency 
to intellectualize emotional experiences (Caligor, Kernberg, & Clarkin, 2007; Summers 
& Barber, 2010). The typically theorized repertoire of defense for OCPD patients 
emphasizes focus on cognition and circumstance over affects (e.g., intellectualization; 
isolation of affect; rationalization); a strong need for control, order, and perfection 
defends against the dangers of experiencing and acting on affect and wishes that feel 
destabilizing. Relative to psychiatrically healthy individuals, OCPD patients report being 
less accepting of their emotions, less clear about what their emotions mean, and more 
distressed by feeling emotional (Steenkamp, Suvak, Dickstein, Shea, & Litz, 2015). In 
treatment with OCPD patients, focusing on affect may help to counteract defenses that 
represent avoidance of emotional conflicts (Barber & Muenz, 1996). We thus 
hypothesized that patients with more OCPD personality traits as indicated by the SCID-II 
(First, Gibbon, Spitzer, Williams, & Benjamin, 1997) would show a stronger relationship 
between early levels of emotional expression and later symptomatic improvements, as for 
these patients emotional expression may particularly indicate a more flexible use of 
defense in-session, relative to their typical profile. 
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 In contrast, we hypothesized that patients with increasingly more BPD traits 
would show no or even negative relationships between early emotional expression and 
later improvements. While BPD is a relatively uncommon comorbidity to PD (Friborg, 
Martinussen, Kaiser, Overgard, & Rosenvinge, 2013), many patients exhibit elevated 
BPD pathology. In general and clinical populations, qualifying for even one DSM-
defined BPD criterion is uniquely prognostic of significant interpersonal dysfunction and 
psychosocial disability (Ellison, Rosenstein, Chelminski, Dalrymple, & Zimmerman, 
2016; Zimmerman, Chelminski, Young, Dalrymple, & Martinez, 2012), indicating that 
even non-diagnostic BPD may be clinically relevant. Affective dysregulation is a 
common if not defining feature of BPD. BPD patients show stronger reactivity to 
interpersonal events (Santangelo, Bohus, & Ebner-Priemer, 2012), as well as more labile 
mood around a more negative baseline (Ebner-Priemer et al., 2015), relative to healthy 
controls and MDD patients. Accordingly, the therapist’s efforts to help patients regulate, 
understand, and usefully work with difficult-to-comprehend affects has been identified as 
a common feature across many empirically supported psychotherapies for BPD 
(Bateman, Gunderson, & Mulder, 2015). For patients with more BPD traits, relatively 
lower levels of emotional expression in PFPP may reflect successful work by the 
therapist and patient to contain affect in order to better work with the meanings and 
circumstances surrounding panic and anxiety (Fonagy & Luyten, 2009). Relatively lower 
emotional expression may also indicate defensive flexibility among BPD patients, who 
typically engage in defenses focusing on prominent, moment-to-moment affects (e.g., 
splitting; acting out; Kramer, de Roten, Perry, & Despland, 2013; Perry, Presniak, & 
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Olson, 2013), such that emotional expression per se may sometimes involve typical 
defensive processes and not primarily a flexible use of defense or processing of conflict. 
Method 
Participants 
Patients. The present study is a secondary analysis of patients randomized to the 
PFPP condition (N = 80) of a two-site randomized controlled trial comparing PFPP, 
CBT, and applied relaxation training among patients with primary DSM-IV panic 
disorder with or without agoraphobia. Patients were recruited at <site A> and <site B>. 
Participants received study treatment gratis. Participants gave informed written consent. 
Both sites’ institutional review boards approved the protocol, and the study is registered 
with ClinicalTrials.gov (identifier: NCT00353470).  
Patients were included in the trial if they had one or more weekly spontaneous 
panic attacks for the month before trial entry, and qualified for DSM-IV diagnosis of 
primary panic disorder with or without agoraphobia determined as per the ADIS-IV 
(DiNardo, Brown, & Barlow, 1995). Cross-site agreement on ADIS ratings for panic 
severity (with a “4” indicating the diagnostic threshold) was excellent (ICC = 1.00; per 
the norms of Portney & Watkins, 2000). See Milrod et al., 2016 for further details. 
Non-study psychotherapy was prohibited. Medications were permitted if stable 
for at least two months at presentation, and were recorded, held constant, and monitored 
during the trial. Exclusion criteria were: active substance dependence (less than 6 
months’ remission), a history of psychosis or bipolar disorder, acute suicidality, and 
organic mental syndrome. Additional details on trial design, independent evaluator 
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training, and therapy adherence can be consulted in the primary outcome paper (Milrod et 
al., 2016). 
Assessment of personality disorder (PersD). The Structured Clinical Interview 
for Axis-II disorders (First et al., 1997) was used to assess the presence of PersD criteria 
and diagnoses as defined by DSM-IV. Trained, independent masters’ level diagnosticians 
uninformed to treatment condition administered the interviews. Cross-site interrater 
reliability was excellent for number of OCPD criteria scored as present (ICC[2,1] = 
1.00), and moderate for BPD criteria (ICC[2,1] = 0.78). 
Therapists. All therapists were experienced therapists (Ph.D. or M.D.) who were 
specifically trained in PFPP over the span of a 2-day, 12-hour course. Therapists had an 
average of 15 years of post-graduate experience (SD = 8.2), and an average of 5 years’ 
experience in some form of time-limited psychodynamic therapy (SD = 6.3). Therapists 
participated in monthly group supervision and received regular individual supervision 
from senior clinicians. For the primary outcome paper, adherence to PFPP was 
established, and additional information on the number and training of therapists can be 
found there (Milrod et al., 2016). 
Outcome Indices 
Panic Disorder Severity Scale (PDSS; Shear et al., 1997). The PDSS is a 
diagnosis-based, composite, global observer rating of panic disorder severity, with 
acceptable psychometric properties. The PDSS was administered by trained, master’s-
level diagnosticians, uninformed as to treatment condition, based on an interview guide. 
Interrater reliability on the PDSS was excellent (ICC[2,1] = 0.95). The PDSS was 
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administered five times during treatment: at baseline (Week 0), Week 1, Week 5, Week 
9, and termination (Week 12).  
Panic-Specific Reflective Functioning (PSRF; Rudden et al., 2006). PSRF is 
an interview-based measure that assesses the degree to which patients can recognize the 
psychological contributions to their panic symptoms. Respondents are queried as to their 
understanding of panic, how it has changed over time, and whether they notice any 
concordance between panic and emotional states. Each response is rated for 
psychological mindedness and complexity, and an overall score is based on item scores. 
An example of a more impaired PSRF answer might be: “It’s the heat, the heat brings 
them on” in response to “Why do you think you have panic attacks?”; a less impaired 
response to that question might be: “I notice that I get them when I am feeling a lack of 
control in my personal relationships. I fear that others will leave me, or that I may want to 
leave them.” PSRF narratives were reliably scored by trained raters (ICC[2,1] = 0.80).  
Process Measures 
Emotional Expression Rating Scale (EERS; Huque & Keefe, 20). The EERS is 
an observer-rated scale developed to assess the degree to which patients are engaged in 
emotional discourse. It was developed for this investigation by two study authors, with 
reference to prior attempts to rate emotions in-session (e.g., Klein et al., 1969; 
McCullough et al., 2003). The measure was designed to be relatively atheoretical and 
broadly descriptive rather than reflecting a particular perspective on what constitutes (for 
example) adaptive emotional experience or deep emotional processing. Contrasted with 
other scales, it was designed for ease of use by individuals with less theoretical or clinical 
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training. To incorporate information on both verbal and non-verbal indicators of 
emotional expression, only sessions with usable video recordings could be sampled. 
Ratings were made every five minutes to allow for a more precise and potentially valid 
assessment of patient emotion expression relative to whole-session ratings, and to collect 
temporal information about development of emotional responses throughout a session. 
Raters made both an omnibus rating for overall emotional expression, and ratings for 4 
broad emotion categories. 
The primary rating concerns a patient’s overall emotional expression, which is 
rated on a 0 to 5 scale. Higher scores are dependent on the peak of emotional intensity 
during the rated segment, but also on the duration of non-neutral emotional expressivity. 
A score of 0 indicates no notable emotional expression, or a relatively neutral or flat 
affective state. A score of 2 indicates a low-to-medium but clear presence of emotional 
expression lasting more than a few seconds, up to a minute, with use of affectively 
charged language or verbal statements of feeling, and non-verbal indicators such as 
choking up, tearing up, emphatic gestures, muscular tension, smiling, or physical 
agitation/restlessness. Scores of 4 and 5 indicate a high, unconstrained peak affective 
arousal with sustained emotional expression across the majority of the rated segment. 
Ratings were made for emotional expression within-session, and not when a patient 
reported how they were feeling in the past, with no clear indication that they are currently 
feeling that particular emotion (e.g., reporting with a neutral tone that they were sad when 
a parent died). In Table 2, examples of transcripts from higher- versus lower-emotional 
expression therapy sessions from the present study are given.  
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Expressions of four specific broad categories of emotions were coded, three of 
which are referenced in the following analyses1:  
 Grief/Sadness: Grief/Sadness referred to the expression of grief, sadness, 
sorrow, or regret. Raters were trained to distinguish between sadness 
surrounding (for example) an interpersonal figure, and indistinct 
depressive distress or self-attack, which was rated as Anxiety/Distress. 
Nonverbal indicators included tearing up, sad vocal tone, choking up, 
quavering voice, frowning, and crying. Raters were trained to pay 
attention to clear verbal expressions of sadness, regret, or loss, or 
particular expressions such as feelings of closeness and tenderness while 
talking about a close attachment figure who died or whom they fear may 
no longer be available to them. 
 Anger/Assertion: Anger/Assertion made a distinction between anger 
directed toward an external or interpersonal figure, and anger directed 
toward the self (e.g., self-attack; self-punishment), which was rated as 
Anxiety/Distress. Anger/Assertion was rated if patients indicated clear 
anger, criticized someone, asserted their needs or desires to someone, or 
voiced wishes for recompense for a past misdeed. Nonverbal markers 
included patients’ showing angry facial expressions, angry vocal tone, 
becoming more tense, clenching their fists, gesturing aggressively, or 
gritting their teeth.  
                                                          
1 Positive Affect was rarely rated as present and had low variance, and consequently we did not analyze 
these scores. 
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 Anxiety/Distress: Anxiety/Distress was intended to be rated when a 
patient appeared activated with clearly negative feeling and arousal, such 
as negative global feelings about the self, anxious tension, or experiencing 
undifferentiated aversive affect. Non-verbal Anxiety/Distress indicators 
included visible discomfort, fidgeting and drawing inwards, 
hyperventilating or full panic attack, and uncontrollable negative affect. 
Verbal indicators included explicit references to feeling anxious or 
distressed or statements of self-attack and hopelessness.  
Correlations between emotion ratings on a per-5 minute basis indicated 
independence of the specific emotions (see Appendix D). 
A total of 15 undergraduate psychology majors were trained on this measure by 
study authors JRK and ZH. Raters were trained by rating sessions not used in this 
investigation until they reliably rated within one point of the trainers. Weekly-to-
biweekly anti-drift sessions were held to maintain reliability and discuss rating 
challenges. Raters were uninformed to patient outcomes and other study patient data. 
Videotapes were coded in a random order, and the average score between three raters was 
used for all analyses.  
Interrater reliability (Shrout & Fleiss, 1979) as calculated in a linear mixed model 
(Bates et al., 2017) was good to moderate per-5 minutes for all emotions (ICC [2,3] 
Overall = 0.74, Grief/Sadness = 0.71, Anger/Assertion = 0.76, Anxiety/Distress = 0.66).  
Statistical Analyses 
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 All analyses were conducted in the R statistical computing language (R Core 
Team, 2017). All primary analyses were run using robust regressions as implemented in 
the R package “Robustbase” (Maechler et al., 2016). Given the effective sample size (n = 
44), robust regression was selected over standard regression for its superior properties of 
robustness against multivariate outliers and deviation from homoscedasticity (Huber & 
Ronchetti, 2009). Semi-partial correlation effect sizes (sr) were estimated for parameters 
of interest. 
Missing data. In the parent clinical trial, a not missing at random (NMAR) 
pattern of treatment dropout was detected, such that patients with worse PDSS symptom 
trajectories were more likely to terminate from treatment prematurely (Milrod et al., 
2016). When outcomes for treatment noncompleters are imputed in the NMAR context, 
imputation and other missing data methods can lead to biased estimates and confidence 
intervals (Graham, 2009). As such, only individuals who provided data up to Week 9 (the 
4th assessment) were eligible for inclusion (n = 65; 81.3% of the intent-to-treat sample). 
Moreover, due to the need for video to rate nonverbal indicators of emotional expression, 
only individuals with videotaped sessions (rather than audio backups) were used. The 
final sample size having videotaped sessions was n = 44. 
Some trial completers were missing one out of three videotaped session due to 
technical issues or therapist/research assistant error (n = 13, 29.5% of the reduced 
sample). In contrast to noncompleters, process ratings for completers missing a video-
recording of a session can be presumed to be missing at random in relation to panic 
symptom outcomes (Rubin & Little, 2002), and psychotherapy process ratings have been 
imputed in past investigations (Keefe, Solomonov, et al., 2018; Lorenzo-Luaces et al., 
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2017). Random forest imputation (Stekhoven & Bühlmann, 2011) was used to impute 
missing data for completers. For this dataset, a normalized root mean square error of 
prediction was estimated at 0.12, indicating that imputation accuracy was estimated to be 
more than adequate (Stekhoven & Bühlmann, 2011).  
Analytic strategy. Using robust linear regressions, the average level of overall 
emotional expression between Sessions 2, 5, and 10 (i.e., three sessions between baseline 
and Week 5) was used to predict subsequent change in PDSS-measured panic 
symptomatology between Week 5 and treatment termination (Week 12). We also 
analyzed PSRF as a secondary outcome. Because site differences were detected in the 
parent trial (Milrod et al., 2016), we explored whether site moderated focal effects for 
this and all subsequently described analyses at a significance of at least p <.10. Control 
covariates in each regression included the baseline value for either outcome, and the 
degree of change in the variable of interest that occurred between baseline and Week 5 
(i.e., during the measurement of emotional expression). In addition, two planned analyses 
of moderators of the relationship between average emotional expression and PDSS 
symptom improvement were conducted: baseline SCID-II OCPD criteria, and SCID-II 
BPD criteria.  
We also performed two secondary, exploratory analyses. First, for both PDSS and 
PSRF change, we examined whether any of three specific types of emotional expression 
(i.e., Grief/Sadness, Anger/Assertion, Anxiety/Distress) were predictive of subsequent 
change. Second, in the context of recent debates about the degree to which stable therapy 
process across sessions merely reflects trait-like features of patients (Falkenström, Finkel, 
Sandell, Rubel, & Holmqvist, 2017), we examined whether having emotional expression 
51 
 
 
 
at Session 10 greater than one’s average across Sessions 2, 5, and 10 predicted 
subsequent symptom change (i.e., a term reflecting Session 10 minus the average of all 
sessions). This analysis also simultaneously controlled for average emotional expression 
within the same model. 
Results 
Descriptive Statistics 
 The average patient in this study had a baseline PDSS score of 13.8 (range 9 to 
20), considered to be in the moderately-ill severity range for patients with comorbid 
agoraphobia (Furukawa et al., 2009). Other patient demographics and clinical 
information can be found in Table 1. 
 Descriptive statistics on mean levels of emotional expression across each session 
can be found in Appendix D. We also examined the consistency of emotional expression 
across measured sessions, using a linear mixed model framework (Bates et al., 2017; 
Appendix D), which revealed that the majority of variance in emotional expression was 
not trait-like across sessions.  
PDSS Symptom Change 
 Patients who had higher levels of emotional expression across the three sampled 
sessions (2, 5, and 10) experienced more panic symptom improvement subsequent to 
Session 10 (B = -3.10 [95% CI: -5.27 to -0.93], SE = 1.07, t[40] = -2.88, p = 0.006, sr = 
0.31), controlling for baseline panic symptoms and prior change in panic symptoms.  
In a secondary analysis, having emotional expression at Session 10 that was 
higher than one’s average emotional expression across Sessions 2, 5, and 10 was also 
predictive of having more symptom improvement subsequent to Session 10 (B = -3.58 
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[95% CI: -5.78 to -1.37], SE = 1.09, t[39] = -3.28, p = 0.002, sr = 0.38). This was true 
even though the model also controlled for a patient’s average level of emotional 
expression, which remained itself a statistically significant predictor of subsequent panic 
symptom improvements (B = -2.90 [95% CI: -4.70 to -1.09], SE = 0.89, t[39] = -3.24, p = 
0.002, sr = 0.29).  
We further explored whether any specific type of emotional expression was 
particularly responsible for this relationship, employing a model simultaneously 
including as predictors average expression levels of grief/sadness, anger/assertion, and 
anxiety/distress. Patients who expressed more grief/sadness across the sampled sessions 
had superior subsequent panic outcomes (B = -5.25 [95% CI: -9.38 to -1.14], SE = 2.18, 
t[38] = -2.41, p = 0.021, sr = 0.28), while neither anger/assertion (B = 2.43 [95% CI: -
1.61 to 6.46], SE = 1.93, t[38] = 1.25, p = 0.217, sr = -0.16) nor anxiety/distress (B = 0.01 
[95% CI: -5.37 to 5.40], SE = 2.68, t[38] = 0.01, p = 0.996, sr = 0.00) were significant 
predictors of symptom change. Figure 1 displays these relationships for overall emotional 
expression and specific emotions. 
Personality Moderators of Symptom Change 
 Next, we examined our moderation hypotheses as to whether BPD and OCPD 
personality traits would predict a smaller or greater relationship (respectively) between 
emotional expression and symptom improvements. Consistent with our hypothesis, the 
number of baseline SCID-II BPD criteria a patient met significantly interacted with 
overall emotional expression, such that meeting more BPD criteria attenuated the 
relationship between overall emotional expression and symptom improvement (B = 2.36 
[95% CI: 1.09 to 3.63], SE = 0.63, t[38] = 3.76, p <.001, sr = 0.29). Unpacking this 
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continuous interaction using the Johnson-Neyman technique, we found that patients 
meeting 1 or no BPD criteria evidenced a significant, positive relationship between 
emotional expression and symptom improvement (sr = 0.33, p = 0.003; see Figure 2).  By 
contrast, there was a nonsignificant, negative relationship between emotional expression 
and improvement for patients meeting 2 or more BPD criteria (sr = -0.20, p = 0.062). 
Thus, patients qualifying for a relatively low number of DSM-defined BPD criteria (2 or 
more) exhibited no beneficial (or potentially even a negative) relationship to degree of 
emotional expression compared to those with minimal (1) or no BPD pathology, who had 
a significant, positive relationship. 
 However, as concerned SCID-II OCPD criteria, there was a significant interaction 
between OCPD criteria, emotional expression, and site (p = 0.036). At Site A, the 
hypothesized interaction was obtained, whereby patients meeting more OCPD criteria at 
baseline had an increasingly positive relationship between early emotional expression and 
subsequent symptom improvement (B = -4.48 [95% CI: -7.72 to -1.24], SE = 1.59, t[34] = 
-2.81, p = 0.008, sr = 0.34). At Site B, there was no significant interaction (B = 0.48 
[95% CI: -2.11 to 3.07], SE = 1.27, t[34] = 0.38, p = 0.707, sr = -0.04). Thus, OCPD 
criteria cannot be considered a clear moderator. 
Panic-Specific Reflective Functioning Change 
 Mirroring the model analyzing symptomatic outcomes, patients with a higher 
level of emotional expression across the three sessions had greater gains in PSRF 
subsequent to the measured sessions (B = 0.93 [95% CI: 0.03 to 1.83], SE = 0.45, t[40] = 
2.10, p = 0.042, sr = 0.23), controlling for their baseline PSRF and early PSRF changes. 
Neither the number of OCPD (B = 0.42 [95% CI: -0.27 to 1.11], t[38] = 1.24, p = 0.223, 
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sr = 0.21) nor BPD criteria (B = -0.42 [95% CI: -1.12 to 0.27], t[38] = -1.23, p = 0.226, sr 
= 0.20) a patient met significantly moderated this relationship. 
 We examined whether any specific type of emotional expression drove this 
relationship. In this case, there were no specific significant relations as concerned 
expression of grief/sadness (B = 1.43 [95% CI: -1.62 to 4.48], SE = 1.51, t[38] = 0.95, p = 
0.350, sr = 0.15), anger/assertion (B = 1.20 [95% CI: -0.54 to 2.95], SE = 0.86, t[38] = 
1.40, p = 0.170, sr = 0.17), or anxiety/distress (B = -0.15 [95% CI: -2.02 to 1.71], SE = 
0.92, t[38] = -0.17, p = 0.869, sr = -0.02). 
Discussion  
 In panic-focused psychodynamic psychotherapy, patients who engage in more 
emotional expression over the course of the first five weeks of therapy have superior 
symptomatic outcomes across the remainder of the treatment. For interpretive context, 
just under half of the average symptomatic change occurs after the first five weeks of 
treatment (see Table 1). Our results are convergent with findings from psychodynamic 
psychotherapy process studies investigating other operationalizations of emotional 
processing or experiencing in-session  (Abbass et al., 2017; Fisher et al., 2016; Friederich 
et al., 2017; Johansson et al., 2014; Kramer et al., 2015; Town et al., 2013; Town, 
Salvadori et al., 2017). These findings expand the literature on emotions in 
psychodynamic therapy to the context of short-term manualized panic disorder-focused 
treatment, and provide further evidence that emotional expression precedes rather than 
contemporaneously occurs with improvements. This study thus provides relatively 
stronger evidence that emotional expression is a therapy process that may help give rise 
to good outcomes, rather than being merely a product of symptomatic alleviation. 
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Notably, early emotional expression also predicted subsequent gains in PSRF, 
which were found in the broader trial to predict subsequent panic improvements (Barber 
et al., under review). Emotional expression may be reflective of mentalization in-session 
of emotional meanings and conflicts contributing to instances of panic and anxiety. As 
the patient works to tolerate and understand affectively-laden meanings and conflicts, 
they are expected to be able to engage with them rather than feel them as undifferentiated 
anxiety or frightening somatic fantasy (Busch et al., 2012). Emotionally working through 
conflict may also serve to detoxify certain affects, meanings, or wishes for patients, 
which may be typically experienced as distressing, dangerous, uncontrollable, or guilt-
provoking to the point of having a panic attack. 
Clinically, our results suggest that emotionally flat or withdrawn discussions of 
the contributors and contexts of anxiety are unlikely to help a patient substantively 
experience and work with these meanings in psychodynamic therapy. Concordantly, past 
work has found that psychodynamic interventions focused on expression of difficult-to-
express affects appear to be correlated with improvements in anxiety (Pitman et al., 2014; 
Pitman et al., 2017), and that anxiety patients rate as especially helpful attempts to 
explore unexpressed/avoided feelings in-session (Glock, Hilsenroth, & Curtis, 2018). The 
presence versus absence of emotional expression may help a therapist distinguish 
between a patient’s compliant or pseudo-insightful (intellectualized) acquiescence to the 
therapist’s attempts to explore the emotional underpinnings of their anxiety, versus 
productive, affective engagement in the therapeutic process.  
In our exploratory analyses concerning which specific emotions contribute to the 
observed relationships, only expression of grief/sadness significantly predicted 
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subsequent symptom outcomes. PFPP’s clinical theory emphasizes the degree to which 
actual or prospective attachment losses can precipitate panic disorder itself, often because 
patients have difficulty acknowledging the emotional importance of the loss (Busch et al., 
2012; Klass et al., 2009; Milrod, Leon, & Shear, 2004). Expression of grief/sadness may 
sometimes reflect patients engaging with and becoming more tolerant of the true 
emotional impact of the actual or feared loss.  
Anger may not have emerged as a significant predictor despite its role in 
psychodynamic models of panic (Busch et al., 1999; Busch et al., 2012), as anger may 
sometimes have been directed toward figures regarding whom the patient already feels 
comfortable experiencing anger. In PFPP, anger is conceptualized as being repressed 
particularly when the patient is worried that his/her anger will provoke 
separation/retaliation and hence loss of an ambivalently-held attachment figure (Busch et 
al., 1999; Busch et al., 2012; Rudden et al., 2003). As such, access to and expression of 
grief/sadness about loss that might be imagined to emerge as a result of angry feelings 
might indicate a deeper processing of the underlying conflict. Expression of disavowed or 
unconscious anger, for instance regarding attachment figures, may be found to have 
stronger relationships to outcomes compared to general anger. Interestingly, in contrast 
with our findings, in an investigation of intensive short-term dynamic psychotherapy for 
treatment-resistant major depressive disorder, experiencing of anger but not grief was 
related to better depression outcomes (Town, Falkenstrom, Abbass, & Stride, 2017; 
Town, Salvadori et al., 2017). It may be that difficulties tolerating particular, core 
emotions are more common to specific symptoms.  
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Finally, anxiety/distress in-session was nonpredictive of outcome. In PFPP, 
presence of anxiety in-session is not considered negative per se, as for example the 
patient may feel anxious because the therapeutic work is addressing important conflicted 
material, and that anxiety can be dealt with in real-time (Busch et al., 2012). From the 
perspective of PFPP, a therapy that transpires without affects sometimes considered 
“negative” or “inhibitory” (McCullough et al., 2003) may reflect that particular important 
dynamics are not being brought into the treatment by the patient or pursued by the 
therapist. Our metric of Overall emotional expression incorporated all deviations from a 
neutral emotional state—which could include so-called negative/inhibitory affects—in 
part to reflect our interest in emotional engagement in treatment writ large relative to 
therapies in which comparatively minimal affect was mobilized in-session. Other 
investigations with different goals may choose to use a modified version of the EERS 
explicitly excluding Anxiety/Distress codes from consideration in the Overall score, or 
other metrics that attempt to explicitly distinguish negative/inhibitory affects, such as the 
Achievement of Therapeutic Objectives Scale (McCullough et al., 2003). 
 We also examined whether personality disorder traits theoretically related to 
constrained (OCPD) or heightened (BPD) emotional expression moderated the 
relationship between emotional expression and symptom change. OCPD traits only 
moderated the predictive value of emotional expression at one of the two treatment sites, 
such that perhaps unmeasured differences in process or patient population further 
affected this relationship—for instance, patients at Site B in the trial were much more 
likely to be on psychotropic medications and had a significantly higher number of 
medication classes taken (Milrod et al., 2016). On the other hand, the presence of 
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elevated BPD traits diminished the relationship between emotional expression and 
symptom improvements. With patients meeting relatively more BPD criteria (>1), the 
PFPP therapist may wish to focus on helping a patient slow down and contain their strong 
affects to better work with the meanings giving rise to powerful emotional experiences. 
Of note, meeting relatively more subthreshold BPD criteria per se was not a negative 
prognostic indicator for PFPP patients in this trial and in fact BPD symptoms improved 
more in PFPP than in CBT in this study (Keefe, Milrod, Gallop, Barber, & Chambless, 
2018), suggesting that these patients can benefit from PFPP, given therapeutic processes 
that are tailored to their needs. However, few patients in this study met SCID II criteria 
for a full comorbid BPD diagnosis, potentially because acute suicidality was an exclusion 
criterion, limiting our assessments to PD patients with low levels of borderline pathology.  
Limitations and future directions 
Several patients had one session (of three) unavailable to be rated due to 
videotape missingness (n = 13, 29.5% of the reduced sample). However, we employed a 
standard, validated method for imputing missing ratings (Stekhoven & Bühlmann, 2011), 
and a complete data analysis showed similar results. In addition, our effective sample size 
was small (n = 44). 
In our study, average levels of emotional expression on the level of the session 
were relatively low (around a 1 on the 5-point scale), with the range of rated values 
consisting of emotionally flat sessions (mean 0) to heightened but not (consistently) 
highly activated sessions (mean 2). Our obtained relationships for emotional expression 
generally do not include representation of consistently high-to-extremely emotional 
sessions, and it is possible that such consistently high expression would not relate to 
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positive outcomes. There was mixed evidence whether maximum emotional expression 
rated in a session (rather than average across segments) was predictive of outcomes (see 
Footnote 2), with a trend level relationship for grief/sadness (cf. Kramer et al., 2015). 
Emotional expression may also have a different relationship to outcome later in 
treatment.  
Our process measure to assess emotional expression, based on the apparent 
intensity and duration of expression, consisted of a simpler operationalization of 
emotional experiencing/processing than other measures used heretofore by 
psychodynamic and process-experiential researchers. For example, there is compelling 
evidence that in emotion-focused experiential psychotherapy (Greenberg, 2015), a 
prototypical sequence of emotional processing moves from feelings of undifferentiated 
global distress toward feeling self-assertive anger or adaptive, relieving experiences of 
grief over past hurts and losses (Pascual-Leone, 2017). It could also be that emotional 
expression at particular moments in therapy—such as discussing specific relationship 
episodes—may be a stronger marker of good process.  
Emotional expression as measured by the EERS also did not attempt to 
distinguish between more versus less adaptive expressions. We were instead primarily 
interested in how manifest emotional expression was a marker of good clinical process in 
this treatment. Defining adaptive versus maladaptive/inhibitory affect in-session is a 
potentially important but complex task, and different psychodynamic approaches use 
varying lenses for understanding affect as a treatment mechanism (for a broad survey of 
heterogeneity in defining adaptiveness of affect in different therapy schools, see the 
different measures used in the Peluso & Freund et al., 2018 meta-analysis). What is 
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“adaptive” affect may also strongly differ from patient to patient: for many patients 
entering PFPP, expressing anger to a romantic partner might be a novel experience contra 
their typical defenses against aggression, whereas for a patient with a more borderline 
personality organization this same action could more frequently reflect splitting as a 
defense. To our knowledge, our study is one of the first to examine how patient context 
(e.g., BPD traits) influences how emotional expression relates to treatment success; such 
personalized examinations may more specifically elucidate the vagaries of emotional 
process in-session, even when using scales that aim to identify only adaptive or deep 
emotional expression. 
However, one advantage of our method is that, by definition, for more nuanced 
emotional experiencing or processing to take place, a basic level of emotional expression 
must nearly always also be present. Future work on this dataset might use our assay of 
emotional expression across segments of sessions to orient and focus more detailed 
research. 
This study does not address the question of how a therapist may best affectively 
engage patients in-session. Process work in psychodynamic therapy indicates that 
focused confrontation interventions (Town, Hardy, McCullough, & Stride, 2012) or 
interventions attempting to orient patients to their affects (Ulvenes et al., 2014) tend to be 
associated with greater emotional experiencing on the part of the patient. Preliminary 
work in this sample suggests that panic-focused interpretations—found to relate to 
subsequent outcomes in PFPP (Keefe, Solomonov et al., 2018)—in one segment of 
treatment may predict higher emotional expression in the next segment of treatment when 
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patients were discussing an attachment relationship (Keefe, Huque et al., 2018). This 
research is ongoing. 
We also did not examine the extent to which patients engaged in emotional 
expressions in the CBT and applied relaxation therapies in the trial. In CBT for 
depression, some studies report that emotional processing in-session may predict better 
post-treatment outcomes (Aafjes-van Doorn & Barber, 2017), but the role of emotional 
processing and experiencing is less commonly explored in this family of treatments. In 
CBT for panic, we might expect emotional expression to be unrelated or positively 
related to treatment outcomes (e.g., restructuring “hot cognitions”; intensely engaging in 
interoceptive exposure). For applied relaxation, emotional expression may have a 
negative relationship to outcomes, given the goal of in-session progressive relaxation. 
Future work could apply the EERS or other experiencing scales to less affect-focused 
psychotherapies for panic. 
Finally, in psychotherapy research, there has been increasing attention on 
distinguishing a patient’s tendency to have a given process score across all sessions (i.e., 
the “between-patients” component) from within-patient changes in process scores, 
accounting for their average levels of that process (Falkenström et al., 2017). Our 
secondary analysis partially addresses this critique, suggesting that having higher than 
one’s average level of emotional expression (Sessions 2, 5, 10) at Session 10 predicted 
superior subsequent symptom improvement, even when simultaneously modeling the 
predictive value of one’s average (i.e., “between-patients”) emotional expression. This 
provides limited evidence that, even among patients who have a relatively higher level of 
emotional expression across their early therapy, emotional expression over one’s typical 
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level at a later session is positively prognostic of symptom improvement. Moreover, the 
majority of variance in emotional expression was not trait-like and consistent across 
patient sessions, indicating that it is less likely (though not impossible) that the “between-
patients” component of emotional expression is primarily driving the observed relations. 
On the other hand, consistently high levels of a particular process, such as emotional 
expression, may also reflect specific work within a unique therapeutic dyad, such that the 
same patient working with a different or more/less skillful therapist would not show such 
a pattern. 
Conclusion 
 Emotional expression in short-term psychodynamic treatment of panic disorder 
early in the course of therapy predicts greater symptomatic improvements later in 
treatment, possibly through encouraging insight into the emotional meanings and 
conflicts surrounding episodes of panic and anxiety. These results require replication. 
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Table 2.1 
Descriptive data for baseline characteristics and for symptom change 
Baseline Measure Mean (SD) or # (%) 
Baseline PDSS 13.8 (2.9) 
Baseline to Week 5 PDSS Change -3.9 (4.0) 
Week 5 to Termination PDSS Change -2.9 (2.9) 
Baseline PSRF 3.3 (1.1) 
Baseline to Week 5 PSRF Change 0.9 (1.4) 
Week 5 to Termination PSRF Change 0.0 (1.2) 
SDS 16.9 (6.1) 
HAM-D 10.4 (3.8) 
Agoraphobia Diagnosis 35 (79.5%) 
Age 37.8 (14.0) 
Gender (Female) 31 (70.5%) 
Concurrent Psychopharmacology 12 (27.3%) 
Age of Panic Onset (years) 26.6 (11.2) 
SCID-II OcPD Criteria 2.1 (1.7) 
SCID-II BPD Criteria 1.0 (1.7) 
Note. HAM-D = Hamilton Rating Scale for Depression; IIP = Inventory of Interpersonal 
Problems; PDSS = Panic Disorder Severity Scale; SCID-II = Structured Clinical 
Interview for the Diagnosis of Axis-II Disorders; SDS = Sheehan Disability Scale 
77 
 
 
 
Table 2.2 
Example transcripts from sessions rated high/low in emotional expression 
High Emotional Expression Transcript 
(Session Average 1.75) 
Low Emotional Expression Transcript 
(Session Average 0.28) 
T: Is your boyfriend being on this 
nocturnal schedule and maybe not 
finishing his program a worry for you? I 
feel that you’re frustrated and anxious in 
an immediate sense of what’s going on 
right now, but there’s some concern about 
getting married, proceeding with that. 
P: No, I mean, the pros outweigh the cons 
< quiet, restrained tone of voice>. 
T: I think maybe part of what might go on 
inside is that thinking about these concerns 
is at times a scary, anxiety-provoking 
thought… because you want to proceed 
with marrying him, and the pros outweigh 
the cons, but he’s not taking care of 
himself. 
P: Yes… yes, I guess so. <tearing up> 
Maybe that’s why… I don’t know, I mean, 
he’s really smart, I just hope that he’ll 
soon figure what he wants to focus on… I 
know that in a few years if he didn’t 
he’d… <begins to fully cry, cries for a few 
moments>…<therapist offers tissue>… 
Thank you… 
T: You’re worried about that, and what 
might happen to you both if that were to 
happen. 
P: <teary, weepy> I don’t know. He’s such 
a Type-A perfectionist, I don’t know how 
he keeps spiraling. I’m so worried about 
him all the time, it really gets to me. I’m 
really sad... <coded elevation in 
Grief/Sadness> 
P: It’s awful. I hate saying goodbyes. I 
hate driving my son to the station to say 
goodbye. I hate driving my sister to say 
goodbye. <neutral tone and facial 
expression> 
T: How does it make you feel when you 
do that? 
P: I guess, and this is just pure 
speculation, but I guess… 
T: What is it that you feel? / P: Um. / T: 
Sorry I cut you off. / P: No, that’s fine. It 
makes me feel anxious, it makes me feel 
sad, um, it’s just very hard, I don’t like it 
at all <laughter; smiling incongruously to 
statement>. 
T: Just like the way you feel here. 
P: When I have tears, they could literally 
be for you and what you’re going 
through, they could be for us, or it could 
be, I don’t know. Because, I mean, there 
would have to be a thought associated 
with the emotion. A thought that, I’m 
assuming, triggered the emotion. 
<continued neutral tone/expression> And 
I don’t know what that thought is. I’d like 
to know what that thought is. But, um, the 
leaving I don’t like. I don’t like goodbyes. 
Never liked goodbyes. Well, I don’t know 
if that’s true, but I don’t like goodbyes. 
<coded small elevation in 
Anxiety/Distress from increase in 
physical agitation and pace of speech, but 
overall still relatively neutral/flat> 
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Note. Both transcripts are adapted from sessions from the trial, particularly Session 10, 
for a patient with one of the top 3 ratings for emotional expression at this session versus a 
patient with one of the bottom 3 ratings for emotional expression. Transcripts have been 
edited for clarity and to eliminate potentially identifying information.  
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Figure 2.1. Estimated effect sizes for the relationship between the average level of 
emotion expression across sessions 2, 5, and 10, and subsequent improvement in panic 
symptoms as measured by the PDSS. Positive semipartial correlations indicate that higher 
levels of expression are associated with more subsequent symptom improvement. Bars 
are 95% confidence intervals.  
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Figure 2.2. Estimated change in panic symptoms as measured by the PDSS between 
Weeks 5 to Termination (Week 12), as a function of the average overall emotional 
expression between sessions 2, 5, and 10, and their interaction with the number of SCID-
II borderline personality disorder criteria a patient met at baseline. Increasingly negative 
values represent greater predicted symptom improvement. All regression variables not 
displayed in the figure were set to the sample means. 
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What Mechanism Works for Whom in Panic 
 
Heterogeneity between patients within a DSM-described disorder is widely 
recognized clinically and, increasingly, empirically. Personalized medicine approaches to 
psychiatric treatment seek to capitalize on this heterogeneity either by matching patients 
to the treatment most likely to target their primary and comorbid DSM disorders, or, for 
psychotherapies, by modifying a given treatment to best address the needs of a given 
patient (Cohen & DeRubeis, in press). 
While some dominant models of psychiatry operate explicitly or implicitly from a 
latent trait conception—that different symptoms emerge from an underlying, common 
disease—an alternative conception is that different causal biopsychosocial factors 
interacting with one another (e.g., in a network) may promote and maintain different 
patterns of presenting symptomatology (Hofmann, Curtiss, & McNally, 2016; Kendler, 
Zachar, & Craver, 2011). Treatment selection models attempting to precisely allocate 
patients on the basis of their personal characteristics to the treatment most likely to 
benefit them may capitalize on the fact that different treatments activate different 
mechanisms of change, which might be more or less likely to help a particular patient 
(DeRubeis, Cohen, et al., 2014; Wallace, Frank, & Kraemer, 2013). If linked factors may 
cause symptoms to correlate and “hang together” in a disorder-like manner (Kendler et 
al., 2011), there is no particular reason why two individuals must share the same pathway 
to manifesting an overt, diagnosable symptom. For example, a longitudinal network 
analysis of symptoms and experiences among depressed and anxious patients examined 
how a patient’s reports of these factors at one time point predicted higher or lower levels 
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of the other measured variables at a subsequent timepoint (e.g., from feelings of anger at 
T0 to depressed mood at T1) (Fisher, Reeves, Lawyer, Medaglia, & Rubel, 2017). While 
some cross-patient commonalities could be extracted across networks of relationships 
between the measured psychological variables across time, patients nevertheless 
exhibited substantive heterogeneity in their networks. For patient A, sleep deprivation 
could lead most to lowered mood, while for patient B, experiences of anger were most 
related to later lowered mood. This suggests that patients with the same set of symptoms 
could differ in the paths that led to their development.  
This view has strong implications for mediation analyses that aim identify a 
potential mechanism by which a treatment leads to the amelioration of symptoms of a 
disorder. A mechanism can be improvement in a process that led to symptom 
development (e.g., defense mechanisms; Perry & Bond, 2012) or a gain in a capacity that 
counteracts a psychopathological process (e.g., cognitive therapy skill use; Strunk, 
DeRubeis, Chiu, & Alvarez, 2007). If such changes are found to promote symptom relief 
in some patients and not others, and insofar as this can be predicted on the basis of 
measurable, individual differences, the term moderated mediation is applicable (Preacher, 
Rucker, & Hayes, 2007).2 Differential responsiveness between patients to change in 
                                                          
2 Note that the term “moderated mediation” has been used to characterize instances in which the 
symptomatic impact of a psychological change is dependent on the type of treatment a patient received 
(e.g. (Zilcha-Mano et al., 2016)). The theoretical implications of this type of finding are arguably unclear. 
If a particular psychological change X is helpful in treatment A but not treatment B, this would necessitate 
that at least one of the following is also true: (a) there is another change encouraged by treatment A but not 
B that, when combined with change X, allows for X to have a salutary effect; (b) there is another change 
encouraged in treatment B but not A that attenuates the impact of change X; or (c) the treatment a patient 
receives affects the meaning of scores (in one treatment or both) on the measure that assesses change X, 
such that shifts in the scores that index X reflect different constructs in treatments A and B.  
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psychological mechanisms may indicate more or less precise targeting of their particular 
deficits or dysfunctions that maintain their symptoms.  
Mechanisms of change in therapies for panic disorder 
We examined the notion of moderated mediation in the context of a 2:2:1 
randomized, two-site controlled trial (Milrod et al., 2016) of cognitive-behavioral therapy 
(CBT; Craske, Barlow, & Meadows, 2000) and panic-focused psychodynamic 
psychotherapy (PFPP; Busch, Milrod, Singer, & Aronson, 2012) for the treatment of 
panic disorder with and without agoraphobia.3 We predicted that individual patient 
differences would influence the symptomatic impact of change in two putative mediators 
of panic improvement, catastrophic cognitions concerning bodily sensations (Clark, 
1986), and panic-specific reflective functioning (PSRF) concerning the interpersonal-
emotional contexts and triggers of panic and anxiety (Rudden, Milrod, Target, Ackerman, 
& Graf, 2006). 
Cognitive-behavioral therapy (CBT) and psychodynamic therapy (PDT) for the 
treatment of panic are each associated with their own theory of the nature of panic attacks 
and of the mechanisms that treatment will marshal to ameliorate panic disorder. There is 
increasing evidence that changes in panic-related cognitions can precede and predict 
improvements in panic symptoms (Lorenzo-Luaces, Keefe, & DeRubeis, 2016). In CBT 
models of panic disorder, catastrophic cognitions concerning the ramifications of specific 
                                                          
3 The ART condition was not included in the present investigation due to the smaller group of patients 
randomized to ART, in addition to significantly higher dropout that was related to being more 
symptomatically and psychosocially impaired at baseline (only in ART), and having worse symptomatic 
trajectories during treatment. These facts imply that the few treatment-completing ART patients were 
particularly unrepresentative compared to CBT and PFPP patients. 
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frightening body sensations, found to be elevated among patients with panic disorder 
compared to other anxiety disorders (Clark et al., 1997), are considered causal to the 
emergence of panic attacks (Clark, 1986). Panic patients are conceptualized as frequently 
interpreting normal body sensations or day-to-day anxiety as indicating somatic problems 
and distress, which initiates a vicious cycle of increases in arousal and a belief that a 
catastrophe is imminent, leading to a panic attack. Cognitive restructuring of these 
cognitions is thought to alleviate panic as it disrupts the cycle of interpretation and 
arousal. (Teachman, Marker, & Clerkin, 2010), reported that improvements on the Brief 
Body Sensations Interpretation Questionnaire (BBSIQ), a measure of catastrophic 
interpretation, predicted subsequent improvements in core panic and agoraphobic 
symptoms in CBT. Barber and colleagues (under review) replicated this finding, and 
found that this pattern held also in panic-focused psychodynamic psychotherapy (PFPP; 
Busch, Milrod, Singer, & Aronson, 2012). 
By contrast, psychodynamic theories of panic emphasize how the inability to 
recognize, experience, and tolerate affects and fantasies that lead to anxiety promotes 
panic. From a psychodynamic perspective, these causes often derive from unconscious 
conflict (e.g., repressed anger against a loved one you are fearful of losing if anger is 
acknowledged). Panic patients report high alexithymia and experiential avoidance 
(Galderisi et al., 2008; Izci et al., 2014; Parker, Taylor, Bagby, & Acklin, 1993; Tull & 
Roemer, 2007) and, despite the fact that in the DSM, a panic attack is defined as 
appearing to “come out of the blue,” emotional-interpersonal anxiety triggers can often 
be identified (Busch, Shear, Cooper, Shapiro, & Leon, 1995; Chambless, 2010; Klass et 
al., 2009; Scocco, Barbieri, & Frank, 2007). Moreover, panic patients exhibit 
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emotionally-avoidant strategies in response to both positively- and negatively-valenced 
stimuli (Tull & Roemer, 2007), and experimentally inducing use of these strategies 
promotes distress and physiological arousal (Tull, Jakupcak, & Roemer, 2010). This lack 
of awareness of triggers, whether facilitated by ignorance or avoidance, can produce the 
upsetting sense that arousal and consequent panic comes "out of the blue” (Busch et al., 
1995). Panic-specific reflective functioning (PSRF), which refers to the tendency of an 
individual to be aware of and to understand emotional meanings surrounding panic, is 
typically impaired in patients with PD (Rudden, Milrod, Target, Ackerman, & Graf, 
2006). Early improvements in PSRF were found to predict subsequent symptom change 
in both PFPP and CBT, controlling for early symptom change (Barber et al., under 
review). These results are consistent with research findings on gains in insight in the 
context of psychodynamic psychotherapy in treating other disorders, which typically 
demonstrate that patients who have improved insight over the course of psychotherapy 
show further or more stable improvements across post-treatment follow-up (Gibbons et 
al., 2009; Johansson et al., 2010; Kallestad et al., 2010; Ulberg, Amlo, Dahl, & Høglend, 
2017).  
Moderation Hypotheses 
For both the BBSIQ and PSRF, we hypothesized that improvements in the BBSIQ 
and PSRF were expected to be more predictive of subsequent symptom improvement 
when a patient’s baseline values for that measure were in the more impaired range. We 
based this on the conjecture that, for patients with these clinical impairments, these core 
problems likely have a greater role in sustaining the symptom disorder. In other words, 
we proposed that the presence of impaired values on these measures would indicate the 
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presence of a problem that must be addressed and compensated for, rather than indicating 
an area of rigid dysfunction that implies therapist should help bolster and mobilize other, 
already stronger capacities (Cheavens, Strunk, Lazarus, & Goldstein, 2012). We therefore 
tested baseline values of each change variable as moderators of the impact of change in 
both BBSIQ and PSRF. 
We also examined the role of co-morbid personality disorder (PersD) in the 
change processes for these therapies. A little less than 50% of panic patients meet criteria 
for a SCID-II diagnosable comorbid personality disorder (Friborg, Martinussen, Kaiser, 
Øvergård, & Rosenvinge, 2013; Keefe, Milrod, Gallop, Barber, & Chambless, in press), 
and anxiety patients with PersD experience worse trajectories of symptom improvements 
over time generally (Ansell et al., 2011; Skodol, Geier, Grant, & Hasin, 2014) and in 
CBT for panic specifically (Porter & Chambless, 2015). Studied mechanisms of change 
in personality disorder are generally based on personality change (or, in the case of DBT, 
acquisition of skills) rather than the change processes studied in this investigation (Keefe 
& DeRubeis, 2018). Psychotherapy with PersD-comorbid patients may sometimes 
require adaptations in technique (Keefe, Webb, & DeRubeis, 2016). Taken together, we 
hypothesized that the personality factors giving rise to PersD may also help contribute to 
panic experiences, and that thus the presence of PersD could attenuate and render less 
primary the relationship between BBSIQ and PSRF improvements and symptomatic 
response. 
Method 
Participants 
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The present study is a secondary analysis of 138 of 201 patients randomized to 
three psychotherapy treatments in a two-site randomized controlled trial comparing CBT, 
applied relaxation training, and PFPP among patients with primary DSM-IV panic 
disorder with or without agoraphobia. Patients were recruited at Weill Cornell Medical 
College and the University of Pennsylvania. Participants received study treatment gratis. 
Participants gave informed written consent. Both sites’ institutional review boards 
approved the protocol, and the study is registered with ClinicalTrials.gov (identifier: 
NCT00353470).  
Patients were included in the trial if they had the spontaneous occurrence of one 
or more panic attacks for the month before trial entry, and qualified for a primary DSM-
IV panic disorder with or without agoraphobia diagnosis determined as per the ADIS-IV 
version (DiNardo, Brown, & Barlow, 1995). Cross-site agreement on ADIS ratings for 
panic severity (with a “4” indicating the diagnostic threshold) was excellent (ICC = 1.00). 
See Milrod et al., 2016 for further details. 
Additional ongoing psychotherapy was prohibited. Medications were permitted if 
stable for at least two months at presentation, and were recorded, held constant, and 
monitored during the trial. Exclusion criteria were active substance dependence (of less 
than 6 month’s remission), a history of psychosis or bipolar disorder, acute suicidality, or 
organic mental syndrome. Additional details on trial design, diagnostician training, and 
therapy adherence can be consulted in the primary outcome paper (Milrod et al., 2016). 
Therapies 
PFPP is based on the central assumption that panic symptoms have a partly 
unconscious psychological meaning. It explores feelings and subjective content of panic 
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episodes, so the patient can begin to address these meanings rather than experiencing 
conflicts physically as somatic anxiety leading to panic (Busch et al., 2012; Milrod et al., 
1997). The therapy helps patients understand and alter core conflicts (e.g., regarding 
attachment and dependency) to avert future panic vulnerability. CBT for PD followed a 
modified version of the Panic Control Therapy protocol (Craske et al., 2000), entailing 
education about panic, correction of maladaptive thoughts about anxiety and body 
sensations, and both in-session and homework interoceptive exposures to bodily 
sensations designed to mimic those experienced during panic (Craske et al., 2000). Both 
psychotherapies comprised 24 sessions delivered twice weekly (12 weeks). Additional 
information on treatments, including training, supervision, and adherence monitoring, can 
be found in Milrod et al. (2016). 
Outcome Index 
Panic Disorder Severity Scale (PDSS; (Shear et al., 1997)). The PDSS is a 
diagnosis-based, composite, global rating of panic disorder severity, with acceptable 
psychometric properties. The PDSS was administered by trained, master’s-level 
diagnosticians who were uninformed as to treatment condition. Interrater reliability on 
the PDSS was excellent (ICC[2,1] = 0.95). The PDSS was administered five times during 
treatment: at baseline (Week 0), Week 1, Week 5, Week 9, and termination (Week 12). 
The mediational analyses in this manuscript concern PDSS change between Week 5 to 
termination (Week 12), controlling for early PDSS change from Week 0 to Week 5. 
Psychological Change and Moderator Measures 
Brief Bodily Sensations Interpretation Questionnaire (BBSIQ; Clark et al., 
1997). The BBSIQ is a 7-item measure of catastrophic misinterpretation of panic-related 
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bodily sensations. Respondents read seven scenarios about bodily sensations, and rank 
three provided interpretations in the order by which they would most likely come to the 
respondent’s mind in that scenario. A score for each item is determined as a function of 
the reported order and the level of catastrophizing of the interpretation, and the item 
scores are summed. The BBSIQ exhibits psychometric consistency conforming to a one-
factor solution, in addition to strong construct validity and test-retest reliability over three 
months. It showed adequate internal consistency in this trial (Cronbach’s α = 0.86).  
Panic-Specific Reflective Functioning (PSRF; Rudden et al., 2006). PSRF is 
an interview-based measure that assesses the degree to which a patient can recognize the 
psychological contributions to panic symptoms. Respondents are queried as to their 
theory of panic, how it has changed over time, and whether they notice any concordance 
between panic and particular emotional or interpersonal states. Each response is rated for 
its psychological mindedness and complexity, and an overall score is assigned based on 
the item scores. An example of a more impaired PSRF answer might be saying “It’s the 
heat, the heat brings them on” in response to “reasons for your panic attacks.” A less 
impaired response to that same question might be “I notice that I get them when I am 
feeling a lack of control in my personal relationships. I fear that others will leave me, or 
that I may want to leave them.” PSRF narratives were reliably scored by three trained 
raters at the Weill-Cornell Medical College (ICC = 0.80).  
Structured Clinical Interview for Axis-II Disorders (SCID-II; First, Gibbon, 
Spitzer, Williams, & Benjamin, 1997). The Structured Clinical Interview for Axis-II 
disorders (First et al., 1997) was used to assess the presence of PersD criteria and 
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diagnoses as defined by DSM-IV. SCID-II criteria counts rather than diagnostic status 
were employed as a moderator variable for reasons of statistical power and validity 
(MacCallum, Zhang, Preacher, & Rucker, 2002), following research suggesting that 
DSM-IV PersD reflects a continuum of illness rather than categorical taxonomies 
(Harford, Chen, & Grant, 2014; Harford et al., 2013; Haslam, Holland, & Kuppens, 
2012). 
Trained, independent masters’ level diagnosticians, uninformed to treatment 
condition administered the interviews. Cross-site inter-rater reliability for number of total 
PersD criteria scored as present was excellent (ICC[2,1] = 0.92). 
Statistical Analyses 
 Missing data. Due to the nonrandom nature of dropout in this trial, wherein 
patients with worse symptom improvement trajectories tended to drop out significantly 
more, and because early psychological changes on the BBSIQ and PSRF were the crucial 
predictors in this study, we could not use early dropout patients in our investigation (n = 
24 in CBT/PFPP; 14.8% dropout rate), resulting in a final sample size of n = 138 across 
the two arms. Attempts to multiply impute their outcome and predictor values would 
likely be statistically biased due to the nonrandom dropout (White, Royston, & Wood, 
2011). As a result, 138 CBT and PFPP patients who performed assessments through at 
least Week 5 (Assessment 3) were the focus of this study. 
Modeling. Statistical analyses were conducted in SAS using the PROC MIXED 
command. Repeated measures mixed models were employed on the three PDSS 
evaluations between Week 5 and Termination (Week 12). Random slopes of PDSS 
symptom change across the time unit of week of treatment during the evaluation period 
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were nested in random person-specific intercepts, with an unstructured covariance 
structure. Covariance structures were allowed to vary between the two sites of the trial. In 
every model, the baseline PDSS score and early PDSS change (between baseline and 
Week 5) were entered as covariates. 
Within a mixed model, the primary analyses predicted slopes of PDSS change 
between Week 5 and termination as a function of early change in psychological change 
mechanisms (i.e., on the BBSIQ or PSRF) between baseline and Week 5. Time was 
modeled as linear, following the pattern of change detected in the parent trial. Moderators 
were tested as an interaction between the moderator value, early psychological change, 
and time (p <.05 threshold). Significance of this interaction indicates that the degree to 
which early psychological change predicts subsequent symptom change is dependent on 
baseline levels of the moderator variable. Covariates included baseline PDSS score and 
early PDSS change occurring between baseline and Week 5 (when the mediator was 
measured the second time). Separate models were run for each of the combinations of 
two psychological mechanism variables (BBSIQ, PSRF) and three baseline moderator 
variables (BBSIQ, PSRF, total SCID-II criteria).  
We separately tested whether any of the above three potential moderators found to 
be statistically significant further interacted with site or treatment at p <.10. However, no 
such interactions emerged, indicating that moderation effects were not reliably different 
across sites or treatments. 
Results 
Descriptive statistics 
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 Information on patient demographics and clinical characteristics can be found in 
Table 1. Patients with better PSRF were somewhat less, but not significantly, likely to 
have a catastrophic, body-focused interpretation style as measured by the BBSIQ (r[134] 
= -0.16, p = 0.064). Early improvements on the PSRF (Baseline to Week 5) did not 
correlate with early improvements on the BBSIQ (r[70] = 0.19, p = 0.111). The 
relationship between baseline values in mediator and moderator measures at baseline and 
early mediator change is reported in Table 2. 
Moderators of the impact of PSRF improvements 
As reported in the Barber et al. (in press) paper on mediation in the trial, patients 
who experienced more PSRF improvements during the first five weeks of treatment 
exhibited greater panic symptom improvements over the subsequent seven weeks (B = -
0.47 [95% CI: -0.82, -0.13], t[166] = -2.69, p = 0.008).  
Two of the three tested variables moderated the impact of early PSRF 
improvements on PDSS change. Our primary hypothesis concerning baseline PSRF 
severity was not supported, as baseline PSRF was not related to the degree to which 
improvements in PSRF predicted subsequent symptom change (B = 0.10 [95 CI: -0.20, 
0.39], t[159] = 0.64, p = 0.520). Contrary to our expectation, however, patients who 
engaged in more severe catastrophic interpretations at baseline on the BBSIQ 
experienced more subsequent symptomatic benefits from early improvements in PSRF (B 
= -1.05 [95% CI: -2.06, -0.03], t[151] = -2.04, p = 0.043) (see Figure 1).  
Nevertheless, as hypothesized, personality pathology was a significant moderator, 
as patients with more personality pathology as measured by the SCID-II were less likely 
to experience symptom improvement after gains in PSRF (B = 0.06 [0.00, 0.11], t[158] = 
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2.00, p = 0.047), whereas patients with less personality pathology burden experienced 
relatively more improvement after gains in PSRF. The critical value of this interaction, at 
which point early PSRF change was no longer significantly related to subsequent PDSS 
improvement, was 12 SCID-II criteria, as identified with the Johnson-Neyman technique 
(Johnson & Fay, 1950; see Figure 2). 
Moderators of the impact of BBSIQ improvements 
 Again, as was found in the Barber et al. (in press) paper on overall mediation in 
this trial, early improvements in the BBSIQ (between baseline and Week 5) predicted 
greater subsequent symptom change on the PDSS (B = 0.13 [0.0, 0.25], t[142] = 2.05, p = 
0.042), controlling for baseline PDSS symptom severity and early symptom 
improvement.  
In a test of our moderation hypothesis, we found that patients with higher BBSIQ 
scores at baseline experienced more symptom relief following early improvements on the 
BBSIQ (B = 0.27 [95% CI: 0.05, 0.49, t[140] = 2.43, p = 0.016). Similar to the pattern 
shown in Figure 1 for PSRF improvements, patients with relatively lower baseline 
BBSIQ exhibited no extra symptomatic improvement subsequent to early decreases on 
the BBSIQ, while those with increasingly higher BBSIQ scores at baseline were 
predicted to benefit more and more from BBSIQ improvements. As expected, baseline 
levels of PSRF did not moderate the relationship between BBSIQ change and symptom 
improvement (B = -0.06 [95% CI: -0.16, 0.03], t[131]=-1.28, p = 0.203). The test of the 
hypothesis that a patient’s level of comorbid personality pathology would affect 
negatively the impact of improvements in catastrophic cognitions on symptomatic benefit 
was not supported (B = 0.01 [95% CI: -0.01,  0.03], t[134] = 1.17, p = 0.244). 
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Discussion 
A panic patient’s degree of symptomatic improvement after experiencing a 
particular psychological change in psychotherapy differs significantly as a function of 
their psychological characteristics. For certain patients, focus on helping stimulate 
particular psychological changes might improve the efficacy of their treatment. From a 
theoretical perspective, these results align with models of psychopathology that posit that 
different psychological variables may contribute to what appear to be identical symptoms 
for different patients (Fisher et al., 2017). As such, ameliorating the same putatively 
pathological process or helping a patient gain an apparently adaptive capacity may be 
more helpful for some patients than those same changes will be for others. Moreover, our 
findings align with the viewpoint that patients’ characteristics may meaningfully 
contribute to which kind of treatment they should receive to optimize their chances of 
success (Cohen & DeRubeis, 2018). 
Possessing a more catastrophic style of interpreting bodily sensations indicated 
that patients experienced greater subsequent symptom change from early improvements 
in both catastrophic interpretations as measured by BBSIQ, or insight into the possible 
psychological meanings surrounding panic as assessed by the PSRF. For these patients, 
the cognitive model of panic may be especially applicable (i.e., that such interpretations 
spark and fuel the cycle into panic attacks; Clark, 1986), such that restructuring those 
interpretations more reliably helps patients thwart the panic cycle. By contrast, patients 
without a strong tendency to catastrophize may not benefit as much from attempts to 
reduce this tendency further.  
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We did not expect to detect the apparent moderating influence of catastrophic 
cognitive style on the impact of gains in PSRF. In PFPP, tendency to somatize is 
understood as a defense mechanism. From a psychodynamic perspective, focus on body 
sensations can arise due to a discomfort with the underlying emotions and fantasies 
contributing to physiological arousal—somatization avoids direct acknowledgement of 
these unacceptable, sometimes partially unconscious contents (Busch et al., 2012; Busch 
et al., 1995). Shifting from understanding anxiety and arousal as implying somatic danger 
to deriving from central psychological meanings may help patients to recognize and work 
with those meanings rather than to ascribe arousal to frightening somatic causes, 
especially given a heightened sense of catastrophe.  
By contrast, patients with lower versus higher insight about possible 
psychological meanings of their panic (i.e., PSRF) evidenced equal apparent benefit from 
either type of psychological change. Ergo, patients beginning psychotherapy with little or 
no insight as to possible emotional or interpersonal links to their panic appear to 
nonetheless benefit from work fostering early improvements in PSRF.  
Taken together, these findings imply that patients with a highly catastrophic, 
body-focused interpretation style may need either to ameliorate this cognitive style or 
gain insight into their emotional-interpersonal triggers in order to experience greater 
relief from panic disorder. Both types of changes may commonly reflect patients 
recognizing that bodily sensations do not indicate danger and catastrophe, but rather that 
they are harmless (BBSIQ improvement) or may signify other psychological meanings 
(PSRF improvement). This may also reflect that, while BBSIQ indexes severity of a 
cognitive style that specifically distinguishes and potentially causes panic disorder (Clark 
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et al., 1997), low levels of PSRF may reflect a lack of understanding of symptom links 
that can be gained to help with panic, rather than a deficit particular to panic patients that 
must be improved. It is possible that individual differences concerning the severity of 
more general emotional awareness deficits (e.g., alexithymia; experiential avoidance) 
documented in panic patients may be a better moderator for panic mediational models. 
Unfortunately, it was not possible to meaningfully investigate the case of simultaneous 
improvement in both constructs, as the type of changes a patient experienced was 
dependent on the therapy they received (CBT vs. PFPP), and simultaneous improvements 
were thus uncommon.  
Patients with more personality pathology burden benefitted less from 
improvements in PSRF, while the converse was true for patients with few such traits. 
Indeed, patients without any personality pathology whatsoever exhibited the greatest 
benefit from PSRF improvements. Nevertheless, in this subsample, there was no 
indication that patients meeting more PersD criteria had significantly worse symptomatic 
outcomes in PFPP as compared to CBT. Furthermore, in this trial PFPP was superior to 
CBT in improving comorbid severe PersD symptoms on the SCID-II (Keefe et al., 2018). 
It may be that PFPP’s capacity to treat severely PersD-comorbid patients is due to other 
psychological changes targeted by psychodynamic therapies, such as improvements in 
defensive functioning or attachment security (Johansson et al., 2010; Keefe & DeRubeis, 
2018; Perry & Bond, 2012; Rossouw & Fonagy, 2012). On the other hand, BBSIQ 
improvements were predictive of symptom change regardless of patients’ personality 
pathology, which is consistent with an account that PersD is not a clear contraindication 
to cognitive restructuring for panic symptom relief. 
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This investigation was not designed to elucidate specific techniques or therapeutic 
foci within the two treatments that best promote the psychological changes we examined. 
Most psychological treatments consist of multiple interventions targeting multiple types 
of changes. CBT for panic disorder includes teaching relaxation (a coping skill), 
cognitive restructuring concerning catastrophic thoughts about the body, and both 
interoceptive exposure to feared bodily sensations and in vivo exposures to phobic, panic-
engendering spaces (facilitating extinction and potentially fueling cognitive change). 
Panic-focused psychodynamic psychotherapy also entails several foci, including the 
exploration of dysregulated attachment, the interpretation of transference and of defenses, 
and efforts to enhance the patient’s awareness and tolerance of emotions and fantasy life. 
Different psychological interventions within a given therapy may best encourage the 
types of psychological changes most likely to help a particular patient (Keefe et al., 2016; 
Sasso, Strunk, Braun, DeRubeis, & Brotman, 2015). These kinds of questions require 
further investigation. 
Limitations and future directions 
 Due to the nonrandom nature of dropout in this trial such that patients with worse 
trajectories of symptom change were more likely to drop out, only patients with observed 
data up to at least Week 5 were analyzed in this investigation (14.8% of CBT and PFPP 
patients randomized to treatment).  
 For this analysis, we had the option to explore either a wide range of potential 
moderators of proposed change mechanisms, or to limit our analyses to a select few on 
the basis of theoretical predictions. In the interest of limiting Type I error, we elected to 
test a smaller set of moderators. It is possible that other individual traits exist that would 
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help envisage how each type of psychological change might predict subsequent 
symptomatic improvements. In addition, only two psychological changes relevant to 
panic disorder were examined in the primary mediator analyses for this trial (catastrophic 
interpretations and PSRF), whereas other putative mediators may exist, such as self-
efficacy (Fentz et al., 2013) and improvements in attachment security (Milrod, 2015), 
neither of which were assessed in this trial. In addition, as this is the first investigation of 
its kind in panic treatment, these relationships should be explored in other treatment trials 
with relevant data. 
 Despite our goals to identify which psychological changes might be most 
important for individual patients, our study takes a nomothetic, between-patients 
approach to examining “what mechanism works for whom.” An alternative, personalized 
approach would be to identify these patterns for individual patients, and to examine the 
differential effects of attempting to intervene upon the core problems that sustain an 
individual’s panic (Fisher & Boswell, 2016). For example, if a patient’s tendency to 
catastrophize bodily sensations was observed to reliably predict their experiences of 
panic and anxiety across time, cognitive interventions targeting that tendency may be 
found to be more efficacious in improving panic than other cognitive-behavioral 
interventions (e.g., relaxation training). 
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Table 3.1  
Descriptive data for baseline characteristics and for symptom change 
Baseline Measure Mean (SD) or # (%) 
Baseline PDSS 13.8 (3.6) 
Week 5 PDSS 9.6 (4.2) 
Termination PDSS 6.5 (4.3) 
Week 5 to Termination PDSS Change -3.4 (3.5) 
Baseline PSRF 3.4 (1.4) 
Baseline to Week 5 PSRF Change (CBT / PFPP) 0.0 (1.0) / 0.5 (1.3) 
Baseline BBSIQ 1.9 (0.4) 
Baseline to Week 5 BBSIQ Change (CBT / PFPP) -0.2 (0.4) / 0.0 (0.3) 
SCID-II Criteria Count 7.5 (6.4) 
Agoraphobia Diagnosis (% Yes) 112 (81.2%) 
Age 40.00 (13.5) 
Gender (Female) 86 (58.1%) 
Ethnicity (Hispanic) 23 (16.7%) 
Race (Caucasian) 101 (73.2%) 
Concurrent Psychopharmacology 42 (30.4%) 
Note. BBSIQ = Brief Bodily Sensation Interpretation Questionnaire; PDSS = Panic 
Disorder Severity Scale; PSRF = Panic-Specific Reflective Functioning; SCID-II = 
Structured Clinical Interview for the Diagnosis of Axis-II Disorders 
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Table 3.2  
Correlations of baseline moderator values to improvement in BBSIQ and PSRF from 
Baseline (Week 0) to Week 5 of treatment. 
 Baseline BBSIQ Baseline PSRF Baseline SCID-II 
BBSIQ 
Improvement 
0.49*** -0.23* -0.02 
PSRF Improvement 0.06 -0.57*** -0.04 
Notes. Higher scores on the BBSIQ indicate a more pronounced tendency to 
catastrophically interpret body sensations. Higher PSRF scores indicate greater symptom 
insight. * = p<.05; *** = p<.001 
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Figure 3.1. Predicted degree of Week 5 to Termination (Week 12) symptom change 
attributable to early (Baseline to Week 5) improvements in PSRF, as a function of 
baseline severity of catastrophic interpretive style as measured by the BBSIQ (interaction 
p = 0.043). 
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Figure 3.2. Predicted degree of Week 5 to Termination (Week 12) symptom change 
attributable to early (Baseline to Week 5) improvements in PSRF, as a function of 
baseline level of personality disorder pathology as measured by number of criteria met on 
the SCID-II interview (interaction p = 0.047). 
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Appendix A 
Additional notes on statistical analyses (Study 1) 
Random forest imputation. Random forest imputation is a single-dataset 
imputation method that can produce nominally equivalent or more accurate imputations 
compared to standard multiple imputation by chained equations, and can natively handle 
simultaneous continuous/categorical variable imputation and datasets with interactions 
and nonlinear relationships between variables (Liao et al., 2014; Stekhoven & Bühlmann, 
2011; Waljee et al., 2013). Random forest algorithms produce nested prediction or 
decision trees based on splits in continuous or categorical predictor variables (King & 
Resick, 2014). Each individual tree selects a bootstrapped subset of the main data set, and 
at each potential split point allows a random subset of possible predictors to be used, until 
there are no more possible splits to be made. This process is repeated across many 
different forests of trees, wherein predictions for the missing variables are iteratively 
updated and improved with successive models, until a stopping criterion is reached. A 
given imputed data value is based on the average prediction made across several decision 
trees built from multiple subsets of the data and potential predicting variables.  
All baseline data, technique ratings from a rated session not used in this 
manuscript (Session 5), and termination and pre-to-post treatment change scores on the 
PDSS, Sheehan Disability Scale, Inventory of Interpersonal Problems, and Hamilton 
Rating Scale for Depression were allowed to predict missing data in the set, in addition to 
all rated process measures and their constituent items. 
Additional references 
113 
 
 
 
King, M. W., & Resick, P. A. (2014). Data mining in psychological treatment research: A 
primer on classification and regression trees. J Consult Clin Psychol, 82(5), 895-
905. doi: 10.1037/a0035886 
Liao, S. G., Lin, Y., Kang, D. D., Chandra, D., Bon, J., Kaminski, N., . . . Tseng, G. C. 
(2014). Missing value imputation in high-dimensional phenomic data: imputable 
or not, and how? BMC Bioinformatics, 15(1), 346. doi: 10.1186/s12859-014-
0346-6 
Waljee, A. K., Mukherjee, A., Singal, A. G., Zhang, Y., Warren, J., Balis, U., . . . 
Higgins, P. D. (2013). Comparison of imputation methods for missing laboratory 
data in medicine. BMJ Open, 3(8). doi: 10.1136/bmjopen-2013-002847 
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Appendix B 
Additional checks on robustness of obtained findings (Study 1) 
Controlling for therapist effects 
 The packages “lme4” and “lmerTest” in the R statistical language were used 
(Bates et al., 2016; Kuznetsova, Brockhoff, & Christensen, 2016). Therapists were 
specified as a 2nd-level random effect in which patients were nested. When therapist 
effects were examined without fixed effects, there was no statistically significant random 
effect of therapist on PDSS symptom change (ICCT Week 1 to 5 = 0.05, p = 0.600; ICCT 
Week 5 to 9 = 0.00, p = 1.000; ICCT Total Pre-Post Change = 0.08, p = 0.300). The lack 
of estimable effect or statistical significance is likely due to the low sample size and poor 
patient/therapist ratio leading to issues in estimation. On the other hand, the estimate of 
reliable therapist-level variance for total pre-post symptom change (8%) was comparable 
to the range of 6-9% often reported in the therapist effects literature (Lutz & Barkham, 
2015). 
For PDSS symptom change between Weeks 1 and 5 and Weeks 5 to 9, we 
conducted an exploratory analysis to examine whether our technique-outcome findings 
differed notably when simultaneously modeling therapist effects, using the same model 
specifications as the primary analyses (e.g., outcome indices, covariates, technique terms) 
but as applied to a mixed model framework. Unremarkably, there were no p-value shifts 
across the significance level of p <.05, and effect size estimates were comparable. 
Functioning and interpersonal outcomes 
 In our primary analyses, we found that panic-focused interpretations at Session 10 
predicted panic symptom improvement on the PDSS occurring subsequent to Session 10. 
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One possibility is that panic-focused interpretations are conducive to symptomatic 
improvements, but that they do not help other aspects of functioning. As a secondary, 
post-hoc analysis, we explored whether these findings extended to improvements on the 
Sheehan Disability Scale (Leon, Shear, Portera, & Klerman, 1992), a measure of 
psychosocial dysfunction due to mental illness, and the Inventory of Interpersonal 
Problems. Unlike the PDSS, which was assessed several times during the trial, the SDS 
and IIP were administered only pre- and post-therapy. 
Our overall modeling strategy was very similar, with the following exceptions: (1) 
the predicted variable was the final SDS or IIP score; and (2) baseline levels of the SDS 
or IIP were included as a covariate in lieu of baseline PDSS. We retained the degree of 
PDSS symptom change between baseline and Week 5 as a covariate, such that early 
symptomatic progress occurring during the process measurement period could not 
contribute to the apparent relationships (or lack thereof) between process variables and 
non-symptomatic outcomes measured at treatment termination.  
Panic-focused interpretations at Session 10 predicted significantly lower IIP (B = 
-0.27 [95% CI: -0.45 to -0.09], SE = 0.09, t[58] = -2.99, p = 0.004) scores at treatment 
termination, and, at the level of a statistical trend, lower SDS scores (B = -2.42 [95% CI: 
-5.21 to 0.38], SE = 1.40, t[59] = -1.73, p = 0.089). By contrast, panic-focused 
interpretations at Session 2 did not relate to improvements on either the IIP (B = -0.20 
[95% CI: -0.47 to 0.08], SE = 0.14, t[58] = -1.44, p = 0.156) or the SDS (B = -2.64 [95% 
CI: -6.29 to 1.01], SE = 1.82, t[59] = -1.45, p = 0.152). 
These findings are consistent with a perspective that panic-focused interpretations 
at mid-therapy may also encourage improvements in interpersonal functioning, in 
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addition to panic symptom response. However, it should be noted that these analyses are 
less analytically rigorous than our primary analyses, as temporal precedence between 
technique use and symptom change cannot be assured because the SDS and IIP were 
measured pre- to post-treatment.  
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Appendix C 
Supplementary tables (Study 1) 
Table S1  
Examples of Panic-focused Clarification and Interpretation 
Technique Example 
Panic-focused 
Clarification 
Patient: It’s just that I know I might be having a heart attack 
whenever I get that anxious. Everything in my chest is so tight, I’m 
so wound up, I’m so clenched, I just feel like my heart is going to 
give out and die. 
Therapist: You think this even though you’ve been to specialists 
several times, and all tests show you as being in not only OK, but 
apparently remarkably good health for your or any age.  
Patient: Yes, yes, but what if they’re wrong? I’m the one who pays 
the price. 
Therapist: Jane, it’s interesting. Somehow, it seems as though it’s 
easier for you to believe you have a hidden, undiagnosable heart 
defect impenetrable to modern medical science, than think that 
there may be any psychological reason you may be panicking. Part 
of you would rather feel like you’re on the razor’s edge than think 
about whatever it is you’re avoiding. 
Panic-focused 
Interpretation 
Therapist: When you finally saw [your boyfriend], did you feel any 
of that disappointment or anger you described to me last session, 
about his lack of communication? 
Patient: Maybe just a little. But, I know that he’s been so busy 
recently, I can’t consider myself the most important thing all the 
time in his life. That would be so selfish of me. 
Therapist: You’re putting in all this grand effort to welcome him, 
at the same time he’s been treating you poorly. I wonder if it is 
easier for you to try to feel excited, rather than experience your 
disappointment, which might lead you to have to reevaluate the 
relationship. I think that considering the relationship feels very 
dangerous to you, you might break up. I wonder if trying to ignore 
that anger and concern about separation leaves you feeling anxious 
and panicky. 
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Appendix D 
 
Supplementary tables (Study 2) 
Table S2.  
Correlations between emotional expression ratings within the same 5-minute segment. 
 Overall 
Expression 
Grief/Sadness Anger/Assertion Anxiety/Distress 
Overall 
Expression 
1 0.48*** 0.38*** 0.65*** 
Grief/Sadness  1 0.10† 0.24*** 
Anger/Assertion   1 0.01 
Anxiety/Distress    1 
† = p <.10; *** = p <.001 
 
Table S3. 
Average levels of emotional expression per 5-minute segment across sampled sessions. 
 Session 2 (M / SD) Session 5 (M / SD) Session 10 (M / 
SD) 
Overall Expressivity 1.10 (0.43) 0.99 (0.36) 1.04 (0.39) 
Grief/Sadness 0.33 (0.29) 0.19 (0.17) 0.17 (0.19) 
Anger/Assertion 0.30 (0.21) 0.32 (0.26) 0.36 (0.29) 
Anxiety/Distress 0.68 (0.38) 0.66 (0.32) 0.74 (0.37) 
Note. As estimated in a mixed model using the R package lme4 (Bates et al., 2017), 
grief/sadness expression was estimated to significantly decrease within-person as patients 
progressed from sessions 2 to 5 to 10, coded as 0, 1, and 2 time indicators (B = -0.08 
[95% CI: -0.13 to -0.04], SE = 0.02, t[74.8] = -3.67, r = 0.39, p <.001). There were no 
other reliable patterns of change in emotional expression experienced by the average 
patient. 
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Table S4.  
Sources of variance in emotional expression per 5-minute segment. 
 Patient-Level 
Variance 
Session-Level 
Variance (in 
Patient) 
Unique/Residual 
Variance 
Overall Expressivity 29.8% 17.9% 52.2% 
Grief/Sadness 15.2% 14.7% 70.1% 
Anger/Assertion 10.0% 20.6% 69.3% 
Anxiety/Distress 23.6% 27.8% 48.6% 
Note. Patient-level variance indicates the degree to which a given patient was reliably 
more versus less expressive across all of their observed ratings and sessions. Session-
level variance indicates the degree to which patients sometimes have entire sessions that 
are more versus less expressive. Unique/residual variance indicates variability in 
expression that is not predicted by the fact that a rating comes from a given patient, or 
which session of a given patient is being rated. Variance components were extracted from 
a mixed model (Bates et al., 2017) including a random effect of session nested within a 
random effect of patient.  
 
